#LCSM Transcript

Healthcare social media transcript of the #LCSM hashtag.
().
See #LCSM Influencers/Analytics.

Sign up for FREE Symplur Account and Get
  • Create Transcripts with Custom Dates
  • Get Custom Influencer Lists
  • 3x Hashtag Search Results
Sign Up Now
ProfileTweet
Brendon Stiles @BrendonStilesMD
Hi #lcsm crew! I am excited for tonight’s chat. One of my favorite topics. Nothing moves the needle more for cancer patients than #Research! #lcsm
Brendon Stiles @BrendonStilesMD
More info about tonight’s chat at https://t.co/Lx9qF406C9 #lcsm
Jean Parks @geekbabe
RT @BrendonStilesMD: Hi #lcsm crew! I am excited for tonight’s chat. One of my favorite topics. Nothing moves the needle more for cancer…
Brendon Stiles @BrendonStilesMD
If you are out there, please tweet #lcsm our way!
Christine Qiong Wu @wi_qiong
@BrendonStilesMD @lcsmchat Have the talk started? #lcsm
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: Hi #lcsm crew! I am excited for tonight’s chat. One of my favorite topics. Nothing moves the needle more for cancer…
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: More info about tonight’s chat at https://t.co/Lx9qF406C9 #lcsm
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: If you are out there, please tweet #lcsm our way!
Brendon Stiles @BrendonStilesMD
@wi_qiong @lcsmchat Just getting geared up. Please say hello to everyone! #lcsm
#LCSM Chat @lcsmchat
@wi_qiong @BrendonStilesMD Starting right now. #lcsm
Umberto Malapelle @UmbertoMalapel1
RT @StephenVLiu: #ELCC19 Entrectinib data in #NTRK #NSCLC presented by Luis Paz-Ares - RR 70%, median PFS 14.9 months, intracranial RR 67%!…
Polk SBC - DJPolk @polksbc1
RT @livinglife82: Thanks @chrisdraft for an awesome experience to check out the @dallascowboys facilities. The attention to detail shows wh…
Brendon Stiles @BrendonStilesMD
You can read about how to participate in the chat at https://t.co/93SziNyHT6 #lcsm
Bob Steele @steele_bob
Hi Folks, Bob here in Greensboro, NC. #lcsm
Jean Parks @geekbabe
Research is why I’m still alive over 4 yrs after a stage IV dx #LCSM
Laronica Conway @louisianagirl91
RT @BrendonStilesMD: More info about tonight’s chat at https://t.co/Lx9qF406C9 #lcsm
Faces of Lung Cancer @LungCancerFaces
Deana in Los Angeles here. I’ll be tweeting from the @lcsmchat account tonight. #lcsm
Brendon Stiles @BrendonStilesMD
@steele_bob Hi Bob. Hope all is well. Thanks for joining! #lcsm
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: You can read about how to participate in the chat at https://t.co/93SziNyHT6 #lcsm
#LCSM Chat @lcsmchat
RT @geekbabe: Research is why I’m still alive over 4 yrs after a stage IV dx #LCSM
Jean Parks @geekbabe
RT @BrendonStilesMD: If you are out there, please tweet #lcsm our way!
Brendon Stiles @BrendonStilesMD
@geekbabe I love it! Glad you are here. #lcsm
Brendon Stiles @BrendonStilesMD
We'll get started in a few minutes -- please take a moment to introduce yourselves #lcsm
Deb Smith 🦋🌻🦉🐢🌿 @debsmithbeach
Deb here, back in NH after a year of travel all over this amazing continent! Scans next week.... #LCSM
Christine Qiong Wu @wi_qiong
@BrendonStilesMD Hi, Christine @wi_qiong in Canada.#LCSM
Santhosh Ambika @RenoHemonc
RT @g_mountzios: #ELCC2019 : @peters_solange : "Dirty" TKIs targeting multiple molecular pathways revived in the immunotherapy era! @lcsmch
Laura Greco @lgreco_ny
Laura here! #lcsm
Brendon Stiles @BrendonStilesMD
I’m your moderator Brendon Stiles, a thoracic surgeon, patient advocate, and PROUD researcher. #lcsm
Faces of Lung Cancer @LungCancerFaces
Hey #LCSM lung cancer people. #LCSM Chat is happening now! Join us.
Denise Cutlip @dennycee
#lcsm Hey! Happy to be here.
Brendon Stiles @BrendonStilesMD
@debsmithbeach thanks for joining! #lcsm
Janet Freeman-Daily @JFreemanDaily
Sorry I won’t be joining #LCSM Chat tonight—my flight yesterday was cancelled (thanks Denver blizzard) and my airline rebooked me to fly NOW. Have fun talking #Lungcancer research!
Matthew Katz, MD @subatomicdoc
Good evening! Matt Katz, radiation oncologist. I hope everyone is doing well tonight :-) #lcsm
Brendon Stiles @BrendonStilesMD
@lgreco_ny Laura!!!! #lcsm
Brendon Stiles @BrendonStilesMD
@JFreemanDaily We will miss you! #lcsm
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: I’m your moderator Brendon Stiles, a thoracic surgeon, patient advocate, and PROUD researcher. #lcsm
#LCSM Chat @lcsmchat
RT @LungCancerFaces: Hey #LCSM lung cancer people. #LCSM Chat is happening now! Join us.
#LCSM Chat @lcsmchat
RT @JFreemanDaily: Sorry I won’t be joining #LCSM Chat tonight—my flight yesterday was cancelled (thanks Denver blizzard) and my airline re…
Brendon Stiles @BrendonStilesMD
@subatomicdoc The one and only! Thanks for joining. #lcsm
Matthew Steliga MD @SteligaMD
Hello there. Looking forward to a good discussion. Thank you! #LCSM
Narjust Duma M.D. @NarjustDumaMD
@JFreemanDaily You will be missed. #lcsm
Brendon Stiles @BrendonStilesMD
@NarjustDuma Thanks for joining! #lcsm
Flemming Rasmussen @fgrazz
#lcsm
Brendon Stiles @BrendonStilesMD
I would like to disclose conflicts – I chair @lcrf_org & have worked with @astrazeneca & @medtronic. My wife worked @pfizer and now @ppdCRO. These don’t affect opinions expressed tonight. #lcsm
Narjust Duma M.D. @NarjustDumaMD
@steele_bob Hello Bob #lcsm.
Brendon Stiles @BrendonStilesMD
In this week’s chat we hope to explore why research matters for #LungCancer patients and how to learn more about it. #lcsm
Paula @lungcancer1964
RT @lcsmchat: TODAY! Education & advocacy are vital, but... “Nothing moves the needle more for lung cancer patients than research.” Join #L
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: I would like to disclose conflicts – I chair @lcrf_org & have worked with @astrazeneca & @medtronic. My wife worked @p
Brendon Stiles @BrendonStilesMD
@fgrazz Was hoping you would join! Thanks! #lcsm
Matthew Katz, MD @subatomicdoc
@BrendonStilesMD Hi Brendon! Glad to join; I've been distracted by #radonc obscure terminology issues. This is much better :-) I hope you're well #lcsm
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: In this week’s chat we hope to explore why research matters for #LungCancer patients and how to learn more about it. #…
ClaimCompanies.com @claimcompanies
RT @JFreemanDaily: Sorry I won’t be joining #LCSM Chat tonight—my flight yesterday was cancelled (thanks Denver blizzard) and my airline re…
Timothy Craig Allen @TimAllenMDJD
Tim here. #lcsm
Brendon Stiles @BrendonStilesMD
#Research covers a lot of topics – cancer risk factors, early diagnosis, identifying molecular targets, developing new treatments, and more! #lcsm https://t.co/PUmks8IBrM
Matthew Katz, MD @subatomicdoc
RT @BrendonStilesMD: In this week’s chat we hope to explore why research matters for #LungCancer patients and how to learn more about it. #…
Brendon Stiles @BrendonStilesMD
#Research can include basic science, translational science, clinical studies, and population health. #lcsm
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: #Research covers a lot of topics – cancer risk factors, early diagnosis, identifying molecular targets, developing new…
Matthew Katz, MD @subatomicdoc
@TimAllenMDJD Hi Tim! Good to see you :-) #lcsm
Brendon Stiles @BrendonStilesMD
We will get started soon. First, a few reminders…#lcsm
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: #Research can include basic science, translational science, clinical studies, and population health. #lcsm
Brendon Stiles @BrendonStilesMD
Please remember to include #LCSM in ALL your tweets so the other chat participants will see them during the chat #lcsm
Devika Das,MD @DevikaDasMD
@BrendonStilesMD @lcsmchat Deep South , academic VA medical oncologist interested in equity to research access #lcsm
Brendon Stiles @BrendonStilesMD
If you prefer just to listen, please tweet “#LCSM” so we know you’re in the audience #lcsm
Timothy Craig Allen @TimAllenMDJD
@subatomicdoc Back atcha, @subatomicdoc! #lcsm
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: Please remember to include #LCSM in ALL your tweets so the other chat participants will see them during the chat #lcsm
Dr Samer Al-Bothaigi @SalemSamer
Hi all I am Samer General surgery resident From Taiz YEMEN ,middle east Glad to join the chat #lcsm
Brendon Stiles @BrendonStilesMD
I will announce FIVE topics (T1 T2 etc). Please label your responses with T1, T2, etc to make transcript easier to follow. #lcsm
Dr Samer Al-Bothaigi @SalemSamer
RT @BrendonStilesMD: #Research covers a lot of topics – cancer risk factors, early diagnosis, identifying molecular targets, developing new…
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: If you prefer just to listen, please tweet “#LCSM” so we know you’re in the audience #lcsm
Brendon Stiles @BrendonStilesMD
We’ll start with Topic T1 in a minute. Great to have such a diverse group here! Thanks to everyone for joining. #lcsm https://t.co/A1HbOLZ7MO
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: I will announce FIVE topics (T1 T2 etc). Please label your responses with T1, T2, etc to make transcript easier to fol…
Timothy Craig Allen @TimAllenMDJD
RT @BrendonStilesMD: In this week’s chat we hope to explore why research matters for #LungCancer patients and how to learn more about it. #…
Bob Steele @steele_bob
RT @BrendonStilesMD: We’ll start with Topic T1 in a minute. Great to have such a diverse group here! Thanks to everyone for joining. #lcsm
Brendon Stiles @BrendonStilesMD
@DevikaDasMD @lcsmchat Thanks for joining. #lcsm
Brendon Stiles @BrendonStilesMD
T1. Is research just for future patients, or do current patients also benefit? #lcsm
Laronica Conway @louisianagirl91
RT @BrendonStilesMD: T1. Is research just for future patients, or do current patients also benefit? #lcsm
Dr Samer Al-Bothaigi @SalemSamer
RT @BrendonStilesMD: We’ll start with Topic T1 in a minute. Great to have such a diverse group here! Thanks to everyone for joining. #lcsm
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: T1. Is research just for future patients, or do current patients also benefit? #lcsm
Matthew Katz, MD @subatomicdoc
RT @BrendonStilesMD: We’ll start with Topic T1 in a minute. Great to have such a diverse group here! Thanks to everyone for joining. #lcsm
Faces of Lung Cancer @LungCancerFaces
RT @BrendonStilesMD: In this week’s chat we hope to explore why research matters for #LungCancer patients and how to learn more about it. #…
Brendon Stiles @BrendonStilesMD
T1. I believe current patients can benefit. The rapid pace of progress in lung cancer brings new drugs to the clinic at a remarkable pace. #lcsm
Matthew Katz, MD @subatomicdoc
@NarjustDuma @JFreemanDaily Definitely will miss you. Safe travels! #lcsm
Brendon Stiles @BrendonStilesMD
T1. EGFR-, ALK-, ROS1-, BRAF-, MET-, NTRK-based drugs are great examples. So is immunotherapy. #lcsm
Laronica Conway @louisianagirl91
RT @BrendonStilesMD: #Research covers a lot of topics – cancer risk factors, early diagnosis, identifying molecular targets, developing new…
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: T1. I believe current patients can benefit. The rapid pace of progress in lung cancer brings new drugs to the clinic…
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: T1. EGFR-, ALK-, ROS1-, BRAF-, MET-, NTRK-based drugs are great examples. So is immunotherapy. #lcsm
Brendon Stiles @BrendonStilesMD
T1. That is how we got from platinum based chemo for all to this….(from @JordiRemon) #lcsm https://t.co/nLAaZc31C5
Matthew Katz, MD @subatomicdoc
@BrendonStilesMD T1. Research helps us learn what works. Depend upon the type of research, it also helps current patients #lcsm
Bob Steele @steele_bob
RT @BrendonStilesMD: T1. That is how we got from platinum based chemo for all to this….(from @JordiRemon) #lcsm https://t.co/nLAaZc31C5
🤡 @sakditouch128
RT @BairdAM: Mesothelin targeted CAR T cell therapy #ELCC19 #lcsm #mesothelioma https://t.co/qYNf4JXWa9
Jean Parks @geekbabe
@BrendonStilesMD Yeah immunotherapy, @annaffarago & @MGHCancerCenter keeping me going! #LCSM
Flemming Rasmussen @fgrazz
RT @subatomicdoc: @BrendonStilesMD T1. Research helps us learn what works. Depend upon the type of research, it also helps current patients…
Timothy Craig Allen @TimAllenMDJD
RT @subatomicdoc: @BrendonStilesMD T1. Research helps us learn what works. Depend upon the type of research, it also helps current patients…
Brendon Stiles @BrendonStilesMD
T1. A previous study suggested that a government backed research collaboration (SWOG) started in1950’s added 3.34 MILLION years of life for cancer patients! #lcsm
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: T1. That is how we got from platinum based chemo for all to this….(from @JordiRemon) #lcsm https://t.co/nLAaZc31C5
#LCSM Chat @lcsmchat
RT @subatomicdoc: @BrendonStilesMD T1. Research helps us learn what works. Depend upon the type of research, it also helps current patients…
Timothy Craig Allen @TimAllenMDJD
RT @BrendonStilesMD: T1. That is how we got from platinum based chemo for all to this….(from @JordiRemon) #lcsm https://t.co/nLAaZc31C5
Bob Steele @steele_bob
RT @BairdAM: Mesothelin targeted CAR T cell therapy #ELCC19 #lcsm #mesothelioma https://t.co/qYNf4JXWa9
Laronica Conway @louisianagirl91
@BrendonStilesMD @lcsmchat Dr. B! It’s Laronica in Birmingham! 😘👋🏾 I’m here kinda...multitasking! #lcsm
Matthew Steliga MD @SteligaMD
T1 I think that many patients who participate in clinical trials do benefit. They may receive treatment otherwise unavailable, and often undergo more rigorous surveillance/scrutiny which could benefit them. #LCSM
#LCSM Chat @lcsmchat
RT @geekbabe: @BrendonStilesMD Yeah immunotherapy, @annaffarago & @MGHCancerCenter keeping me going! #LCSM
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: T1. A previous study suggested that a government backed research collaboration (SWOG) started in1950’s added 3.34 MIL…
Timothy Craig Allen @TimAllenMDJD
RT @BrendonStilesMD: T1. A previous study suggested that a government backed research collaboration (SWOG) started in1950’s added 3.34 MIL…
Brendon Stiles @BrendonStilesMD
T1. 3.34 million years of life at an estimated cost of $125 for each year of life! https://t.co/HSfiklE65P #lcsm
Ian Pereira @IanJPereira
@lcsmchat @wi_qiong @BrendonStilesMD Hi #lcsm. I’m a #RadOnc resident taking a break from the nomenclature fun for our hashtag project :)
Brendon Stiles @BrendonStilesMD
@IanJPereira @lcsmchat @wi_qiong Wise choice! #lcsm
Bob Steele @steele_bob
RT @BrendonStilesMD: T1. 3.34 million years of life at an estimated cost of $125 for each year of life! https://t.co/HSfiklE65P #lcsm
Narjust Duma M.D. @NarjustDumaMD
@BrendonStilesMD @lcsmchat T1: Research can cover many topics and benefit patients that are receiving treatment today as well as future patients. As well as caregivers and families. What we dont know today but will know tomorrow. #LCSM
Devika Das,MD @DevikaDasMD
@BrendonStilesMD Speaking purely of clinical trials -Certainly future patients ( no doubt) but a lot of the clinical trials are helping current patients as well. #lcsm
#LCSM Chat @lcsmchat
RT @NarjustDuma: @BrendonStilesMD @lcsmchat T1: Research can cover many topics and benefit patients that are receiving treatment today as w…
黒野絵門 Kurono Emon @chroemon
RT @Tony_Calles: VARGADO: Nintedanib + Docetaxel in 3rd line after 2nd line Immunotherapy in NSCLC. Encouraging results from real clinical…
Brendon Stiles @BrendonStilesMD
@louisianagirl91 @lcsmchat Always love having you! #lcsm
Jean Parks @geekbabe
4 yrs covers a lot of birthdays, weddings & graduations #LCSM https://t.co/RhIY3lGubj
Enlightening Results @GraceCordovano
RT @BrendonStilesMD: Remarkable study! Potentially game changing. Congratulations to all. https://t.co/Yd2emaycop
Bob Steele @steele_bob
RT @NarjustDuma: @BrendonStilesMD @lcsmchat T1: Research can cover many topics and benefit patients that are receiving treatment today as w…
#LCSM Chat @lcsmchat
RT @DevikaDasMD: @BrendonStilesMD Speaking purely of clinical trials -Certainly future patients ( no doubt) but a lot of the clinical trial…
Dr Samer Al-Bothaigi @SalemSamer
T1 all people ge benifit from research The change in cancer treatment may change 360 degree in the near future with genetics ,stem cell ,nanotechnology and artificial intellegence #lcsm
Brendon Stiles @BrendonStilesMD
T1. Everyone can benefit from research. But some clinical trials are set up so that patients get “placebo” or standard of care. #lcsm
Ian Pereira @IanJPereira
@BrendonStilesMD Interesting that #funding didn’t show up more in that wordcloud... :) #lcsm T1
Jinbo Yue @yuejinbo
RT @GlopesMd: Have to say that even with this, we should continue preferring chemo + IO instead of IO alone for patients with PDL1 between…
Bob Steele @steele_bob
RT @DevikaDasMD: @BrendonStilesMD Speaking purely of clinical trials -Certainly future patients ( no doubt) but a lot of the clinical trial…
Flemming Rasmussen @fgrazz
On top of @subatomicdoc 's comment 'learn what works' some areas of research allow us to how, and why, and in new ways altogether #lcsm
Narjust Duma M.D. @NarjustDumaMD
@BrendonStilesMD @lcsmchat @JordiRemon T1: Love this illustration! #lcsm
Matthew Katz, MD @subatomicdoc
RT @DevikaDasMD: @BrendonStilesMD Speaking purely of clinical trials -Certainly future patients ( no doubt) but a lot of the clinical trial…
Devika Das,MD @DevikaDasMD
@BrendonStilesMD Implementation research helps quickly take novel research to disseminate them widely and in a timely manner #lcsm. ( often neglected and underfunded)
Brendon Stiles @BrendonStilesMD
T1. Clinical and population science research are critical for understanding trends in treatment and for quality control. It helps everyone! #lcsm
Jean Parks @geekbabe
Research gave me the beach #LCSM https://t.co/uJDeeiklVC
Brendon Stiles @BrendonStilesMD
@IanJPereira True...the crux of the situation. #lcsm
Dr Samer Al-Bothaigi @SalemSamer
RT @geekbabe: Research is why I’m still alive over 4 yrs after a stage IV dx #LCSM
Matthew Katz, MD @subatomicdoc
RT @fgrazz: On top of @subatomicdoc 's comment 'learn what works' some areas of research allow us to how, and why, and in new ways altogeth…
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: T1. Everyone can benefit from research. But some clinical trials are set up so that patients get “placebo” or standa…
#LCSM Chat @lcsmchat
RT @fgrazz: On top of @subatomicdoc 's comment 'learn what works' some areas of research allow us to how, and why, and in new ways altogeth…
Devika Das,MD @DevikaDasMD
RT @BrendonStilesMD: T1. 3.34 million years of life at an estimated cost of $125 for each year of life! https://t.co/HSfiklE65P #lcsm
Jinbo Yue @yuejinbo
RT @n8pennell: To clarify, I am referring to 1-49% PDL1 expressors preferentially being treated with chemo+pembro (not all >1%) and using p…
Brendon Stiles @BrendonStilesMD
T1. A patient (who has become a close friend) got diagnosed with #ALKPositive cancer and >20 brain mets the same month a new drug was approved with better brain efficacy. He is still going strong. #lcsm
#LCSM Chat @lcsmchat
RT @DevikaDasMD: @BrendonStilesMD Implementation research helps quickly take novel research to disseminate them widely and in a timely mann…
Narjust Duma M.D. @NarjustDumaMD
@BrendonStilesMD @lcsmchat T1: In addition, symptoms directed interventions can help patients in real time. #LCSM
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: T1. Clinical and population science research are critical for understanding trends in treatment and for quality contr…
Bob Steele @steele_bob
RT @BrendonStilesMD: T1. A patient (who has become a close friend) got diagnosed with #ALKPositive cancer and >20 brain mets the same mont…
Brendon Stiles @BrendonStilesMD
T1. Good summary from @NCI on return on investment of cancer research: https://t.co/1eMGoy4P1Z #lcsm
Bob Steele @steele_bob
RT @NarjustDuma: @BrendonStilesMD @lcsmchat T1: In addition, symptoms directed interventions can help patients in real time. #LCSM
Christian Rolfo @ChristianRolfo
#OncoAlert #LCSM
Bob Steele @steele_bob
RT @BrendonStilesMD: T1. Good summary from @NCI on return on investment of cancer research: https://t.co/1eMGoy4P1Z #lcsm
Timothy Craig Allen @TimAllenMDJD
RT @BrendonStilesMD: T1. Good summary from @NCI on return on investment of cancer research: https://t.co/1eMGoy4P1Z #lcsm
Matthew Katz, MD @subatomicdoc
RT @geekbabe: Research gave me the beach #LCSM https://t.co/uJDeeiklVC
Brendon Stiles @BrendonStilesMD
@NarjustDuma @lcsmchat Could not agree more. #lcsm
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: T1. A patient (who has become a close friend) got diagnosed with #ALKPositive cancer and >20 brain mets the same mont…
Laura Greco @lgreco_ny
t1: most of the long term survivors I know are alive because of clinical trials. Even though they may "fail" from a commercial/scientific aspect they can buy patient more time. #lcsm
Devika Das,MD @DevikaDasMD
@BrendonStilesMD @JordiRemon Saving this for teaching fellows #lcsm
MaryAnn Brown @MARYANNBROWNMFT
RT @geekbabe: @BrendonStilesMD Yeah immunotherapy, @annaffarago & @MGHCancerCenter keeping me going! #LCSM
Heiko Enderling @theheikman
RT @_ShankarSiva: It's here! SABR-COMET published in @TheLancet - https://t.co/lZmAYZ3xWK - randomised trial of ablation in oligometastast…
#LCSM Chat @lcsmchat
RT @NarjustDuma: @BrendonStilesMD @lcsmchat T1: In addition, symptoms directed interventions can help patients in real time. #LCSM
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: T1. Good summary from @NCI on return on investment of cancer research: https://t.co/1eMGoy4P1Z #lcsm
Kathleen Skambis @KathleenSkambis
#lcsm late
Jean Parks @geekbabe
I visited @MGHCancerCenter lung cancer research lab #LCSM https://t.co/5ICV9RNfwu
#LCSM Chat @lcsmchat
RT @lgreco_ny: t1: most of the long term survivors I know are alive because of clinical trials. Even though they may "fail" from a commerc…
Matthew Katz, MD @subatomicdoc
@BrendonStilesMD @IanJPereira @lcsmchat @wi_qiong Definitely! Good to see you Ian! #lcsm
Brendon Stiles @BrendonStilesMD
T1. Voters want more research! Tell your elected representatives. From @AACR survey. #lcsm https://t.co/Xotv5CRKqy
Matthew Katz, MD @subatomicdoc
RT @BrendonStilesMD: T1. Good summary from @NCI on return on investment of cancer research: https://t.co/1eMGoy4P1Z #lcsm
Devika Das,MD @DevikaDasMD
RT @BrendonStilesMD: T1. Voters want more research! Tell your elected representatives. From @AACR survey. #lcsm https://t.co/Xotv5CRKqy
Dr Samer Al-Bothaigi @SalemSamer
T1 i am sure that will be a revolution in csncers treatment Just like the invention of penicillin which changed the treatment amd prognosis of infections #lcsm
Brendon Stiles @BrendonStilesMD
T2 coming.... #lcsm
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: T1. Voters want more research! Tell your elected representatives. From @AACR survey. #lcsm https://t.co/Xotv5CRKqy
Devika Das,MD @DevikaDasMD
RT @BrendonStilesMD: T1. Good summary from @NCI on return on investment of cancer research: https://t.co/1eMGoy4P1Z #lcsm
Brendon Stiles @BrendonStilesMD
T2. In what areas is more research most needed for lung cancer?#lcsm
Bob Steele @steele_bob
RT @BrendonStilesMD: T1. Voters want more research! Tell your elected representatives. From @AACR survey. #lcsm https://t.co/Xotv5CRKqy
Jinbo Yue @yuejinbo
RT @Tony_Calles: VARGADO: Nintedanib + Docetaxel in 3rd line after 2nd line Immunotherapy in NSCLC. Encouraging results from real clinical…
Jean Parks @geekbabe
Research meant seeing a 1st great grandchild #LCSM https://t.co/hLpyH1eYxF
Laura Greco @lgreco_ny
@BrendonStilesMD @AACR T1: Lung cancer research unfortunately gets short changed at the federal level. We need to emphasize how it makes monetary sense to tackle lung cancer. #lcsm
Deb Smith 🦋🌻🦉🐢🌿 @debsmithbeach
T1. I've been in 3 clinical trials so far and 2/3 have benifitted me significantly! Happy to help future patients, thrilled to have extended my life! I've been on Tagrisso for 5 1/2 yrs, first in a trial. #LCSM
Brendon Stiles @BrendonStilesMD
T2. Geez…I can think of about 1,000 things we need to study more! #lcsm https://t.co/T0nXag4EaN
Timothy Craig Allen @TimAllenMDJD
RT @BrendonStilesMD: T2. In what areas is more research most needed for lung cancer?#lcsm
Brendon Stiles @BrendonStilesMD
@geekbabe @MGHCancerCenter This is great. I will suggest later! #lcsm
Jean Parks @geekbabe
RT @BrendonStilesMD: T1. That is how we got from platinum based chemo for all to this….(from @JordiRemon) #lcsm https://t.co/nLAaZc31C5
Jean Parks @geekbabe
RT @BrendonStilesMD: T1. A patient (who has become a close friend) got diagnosed with #ALKPositive cancer and >20 brain mets the same mont…
Narjust Duma M.D. @NarjustDumaMD
@lgreco_ny @lcsmchat That's right! Disease progression at 12 months is one more birthday for my patient is NOT a failure. #LCSM
Brendon Stiles @BrendonStilesMD
T2. We need to understand why so many patients develop resistance to drugs that initially work. #lcsm https://t.co/hSuGu1OjYm
MaryAnn Brown @MARYANNBROWNMFT
RT @BrendonStilesMD: T1. That is how we got from platinum based chemo for all to this….(from @JordiRemon) #lcsm https://t.co/nLAaZc31C5
Dr Samer Al-Bothaigi @SalemSamer
What make this chat worthy Is that i see lung cancers patients share the chat Glad to see you dear patients God save you #lcsm
Flemming Rasmussen @fgrazz
T1 = @NCI Rtn on investment - Nice summary but even they say we need 'greater progress' Only deeper into current areas, or new paths? #lcsm
Kristin Ito @KAdvocate_LCAM
@BrendonStilesMD Tough question...it all does! But one area in need is, small cell #LCSM
Laura Greco @lgreco_ny
Me too... almost better question is what don't we need to study more! #lcsm
Healthcare-Global @HealthcareGlob1
RT @OncLive: The initial OS analysis of the MYSTIC trial of durvalumab alone or in combination with tremelimumab compared with platinum-bas…
Frank Ingram, MD @Chucktowndoc
Ingram joining a little late. Pathologist from NC. #lcsm
Jean Parks @geekbabe
Research can give patients the gift of time #LCSM https://t.co/9PjchIbEnL
Timothy Craig Allen @TimAllenMDJD
2d that @BrendonStilesMD #lcsm
Bob Steele @steele_bob
RT @TimAllenMDJD: 2d that @BrendonStilesMD #lcsm https://t.co/45XzPyK7Sc
Brendon Stiles @BrendonStilesMD
T2. We need to figure out who is at risk for lung cancer, particularly among never smokers. Data from us @WeillCornell @MeyerCancer #lcsm https://t.co/mJBP6TbZ6F
Jean Parks @geekbabe
RT @BrendonStilesMD: T1. A previous study suggested that a government backed research collaboration (SWOG) started in1950’s added 3.34 MIL…
Percy Lee MD @PercyLeeMD
Practice changing paradigm. #sabr stereotactic ablative radiotherapy for oligometaststic disease state #lcsm #pcsm #bcsm #radonc
Brendon Stiles @BrendonStilesMD
T2. We need to get a better handle on genetic susceptibility to lung cancer. #lcsm
Jean Parks @geekbabe
RT @lgreco_ny: t1: most of the long term survivors I know are alive because of clinical trials. Even though they may "fail" from a commerc…
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: T2. In what areas is more research most needed for lung cancer?#lcsm
Brendon Stiles @BrendonStilesMD
@Chucktowndoc Thanks for joining! #lcsm
#LCSM Chat @lcsmchat
RT @lgreco_ny: @BrendonStilesMD @AACR T1: Lung cancer research unfortunately gets short changed at the federal level. We need to emphasize…
Laura Greco @lgreco_ny
@BrendonStilesMD Yes! We get these fantastic results with TKIs... how lovely would it be if they lasted! #lcsm
Timothy Craig Allen @TimAllenMDJD
RT @BrendonStilesMD: T2. We need to figure out who is at risk for lung cancer, particularly among never smokers. Data from us @WeillCornel
#LCSM Chat @lcsmchat
RT @debsmithbeach: T1. I've been in 3 clinical trials so far and 2/3 have benifitted me significantly! Happy to help future patients, thril…
Flemming Rasmussen @fgrazz
@BrendonStilesMD T2 - drug resistance - would be nice to understand 'why' but also worth exploring areas that may be less susceptible #lcsm
Brendon Stiles @BrendonStilesMD
T2. We need clinical and population health studies to figure out why physicians are doing such a terrible job screening at risk patients for lung cancer! #lcsm
#LCSM Chat @lcsmchat
RT @NarjustDuma: @lgreco_ny @lcsmchat That's right! Disease progression at 12 months is one more birthday for my patient is NOT a failure…
M @MayteMirellaCL
Each day, Dr. Cathy Pietanza is #InventingForLife and helping to improve the outlook for #lungcancer patients: mercurio us/2CyJZeB #AACR19 #LCSM
MaryAnn Brown @MARYANNBROWNMFT
@lcsmchat #LCSM
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: T2. We need to understand why so many patients develop resistance to drugs that initially work. #lcsm https://t.co/hS…
Ian Pereira @IanJPereira
@BrendonStilesMD I have heard it described in different ways, but I believe a clinical trial often offers the best resources to patients on trial. I often wish all institutional changes were treated with as much ethical care. #lcsm T1
Jean Parks @geekbabe
RT @BrendonStilesMD: You can read about how to participate in the chat at https://t.co/93SziNyHT6 #lcsm
#LCSM Chat @lcsmchat
RT @fgrazz: T1 = @NCI Rtn on investment - Nice summary but even they say we need 'greater progress' Only deeper into current areas, or new…
Brendon Stiles @BrendonStilesMD
T2. We need to better understand sequencing of therapy and figure out how to move targeted therapy into earlier stages. This from @JTOonline. #lcsm https://t.co/K8Sw8JaeOi
#LCSM Chat @lcsmchat
RT @KAdvocate_LCAM: @BrendonStilesMD Tough question...it all does! But one area in need is, small cell #LCSM
Brendon Stiles @BrendonStilesMD
RT @fgrazz: @BrendonStilesMD T2 - drug resistance - would be nice to understand 'why' but also worth exploring areas that may be less susce…
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: T2. We need to figure out who is at risk for lung cancer, particularly among never smokers. Data from us @WeillCornel
Flemming Rasmussen @fgrazz
@BrendonStilesMD T2 - In what areas? Understanding pH and the reversed gradient is one of many #lcsm
Shankar Siva @_ShankarSiva
RT @PercyLeeMD: Practice changing paradigm. #sabr stereotactic ablative radiotherapy for oligometaststic disease state #lcsm #pcsm #bcsm #…
Percy Lee MD @PercyLeeMD
@BrendonStilesMD T1: In a randomized study the standard treatment arm is what patients should receive as state of the art care. Under the watch of a study the quality of care should also be top notch due to extensive independent oversight #lcsm
Dr Samer Al-Bothaigi @SalemSamer
T2 We need more researches abt quit smoking Cancers screening Treatment Cancer genetics Immunotherapy #lcsm
Aparna Hegde, MD @notahedge
T2: We need to improve outcomes for non-metastic NSCLC. Need screening and timely adjuvant studies. #lcsm
Brendon Stiles @BrendonStilesMD
T2. We need to better describe patient reported outcomes and side effects. #lcsm
Devika Das,MD @DevikaDasMD
@BrendonStilesMD T2 real world impact of clinical trials , boardly inclusive clinical trials ( brain Mets etc) , racial and socioeconomic disparities in lung cancer care, #lcsm besides all areas of lung cancer need more funding , dismal compared to certain other tumor types
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: T2. We need to get a better handle on genetic susceptibility to lung cancer. #lcsm
Timothy Craig Allen @TimAllenMDJD
#JustMolecularChanges #lcsm
#LCSM Chat @lcsmchat
RT @lgreco_ny: @BrendonStilesMD Yes! We get these fantastic results with TKIs... how lovely would it be if they lasted! #lcsm
#LCSM Chat @lcsmchat
RT @fgrazz: @BrendonStilesMD T2 - drug resistance - would be nice to understand 'why' but also worth exploring areas that may be less susce…
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: T2. We need clinical and population health studies to figure out why physicians are doing such a terrible job screeni…
Devika Das,MD @DevikaDasMD
RT @BrendonStilesMD: T2. In what areas is more research most needed for lung cancer?#lcsm
Matthew Katz, MD @subatomicdoc
@JonJKruse @gdhugo @SBRT_CR @SeanSachdevMD @KimpleRandall @PercyLeeMD @DrChowdharyMD @BrendonStilesMD @IanJPereira @NicholasZaorsky @AshleyAlbertMD @DrAndrewLoblaw @BreastDocUK @_ShankarSiva @sandraturner49 @BK_radiation @UCLAHealth I wish I had more time for #lcsm and other chats. I learn a great deal that informs me on being a better cancer doctor.
#LCSM Chat @lcsmchat
RT @IanJPereira: @BrendonStilesMD I have heard it described in different ways, but I believe a clinical trial often offers the best resourc…
Jean Parks @geekbabe
I participate in every study offered to me. Because... it’s science! #LCSM
Brendon Stiles @BrendonStilesMD
T2. We also need to understand financial toxicity of cancer care today and how that impacts patients and caregivers. #lcsm https://t.co/1Rj1lAuMTj
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: T2. We need to better understand sequencing of therapy and figure out how to move targeted therapy into earlier stage…
#LCSM Chat @lcsmchat
RT @fgrazz: @BrendonStilesMD T2 - In what areas? Understanding pH and the reversed gradient is one of many #lcsm
Ian Pereira @IanJPereira
@DevikaDasMD @BrendonStilesMD Any examples of what you mean by implementation research? #lcsm T1
#LCSM Chat @lcsmchat
RT @PercyLeeMD: @BrendonStilesMD T1: In a randomized study the standard treatment arm is what patients should receive as state of the art c…
#LCSM Chat @lcsmchat
RT @notahedge: T2: We need to improve outcomes for non-metastic NSCLC. Need screening and timely adjuvant studies. #lcsm
Timothy Craig Allen @TimAllenMDJD
#PatientsFirst #lcsm
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: T2. We need to better describe patient reported outcomes and side effects. #lcsm
#LCSM Chat @lcsmchat
RT @DevikaDasMD: @BrendonStilesMD T2 real world impact of clinical trials , boardly inclusive clinical trials ( brain Mets etc) , racial an…
Narjust Duma M.D. @NarjustDumaMD
@BrendonStilesMD T2: I'm an advocate for including ALL patients in clinical trials. We still have knowledge gaps regarding drug tolerability and response in minority groups. Most IO trials included less than 5% AA and Hispanic pts. #lcsm
Brendon Stiles @BrendonStilesMD
@notahedge Could not agree more! #lcsm
Timothy Craig Allen @TimAllenMDJD
RT @BrendonStilesMD: T2. We also need to understand financial toxicity of cancer care today and how that impacts patients and caregivers.…
Marío Pérez Peña @MaroPrezPea1
RT @TimAllenMDJD: 2d that @BrendonStilesMD #lcsm https://t.co/45XzPyK7Sc
Liz Johnson @wired4story
RT @BrendonStilesMD: T2. We also need to understand financial toxicity of cancer care today and how that impacts patients and caregivers.…
Laura Greco @lgreco_ny
Yes! And how about a test that could be generally administered to catch cancer earlier? #lcsm
#LCSM Chat @lcsmchat
RT @geekbabe: I participate in every study offered to me. Because... it’s science! #LCSM
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: T2. We also need to understand financial toxicity of cancer care today and how that impacts patients and caregivers.…
#LCSM Chat @lcsmchat
RT @IanJPereira: @DevikaDasMD @BrendonStilesMD Any examples of what you mean by implementation research? #lcsm T1
Aparna Hegde, MD @notahedge
This 👇. Can we achieve what we've done for breast cancer.
#LCSM Chat @lcsmchat
RT @NarjustDuma: @BrendonStilesMD T2: I'm an advocate for including ALL patients in clinical trials. We still have knowledge gaps regarding…
Devika Das,MD @DevikaDasMD
@IanJPereira @BrendonStilesMD Expanding trials to real world setting - for example how to make NGS accessible in a timely and cost effective manner in rural Alabama etc #lcsm
#LCSM Chat @lcsmchat
RT @lgreco_ny: Yes! And how about a test that could be generally administered to catch cancer earlier? #lcsm https://t.co/4rUjlCn5YT
Narjust Duma M.D. @NarjustDumaMD
@geekbabe Thanks! #lcsm
Flemming Rasmussen @fgrazz
@BrendonStilesMD T2 = better handle on genetic susceptibility, yes, but also to understand the cell env role that is part of the dance #lcsm
Matthew Katz, MD @subatomicdoc
RT @BrendonStilesMD: T2. We also need to understand financial toxicity of cancer care today and how that impacts patients and caregivers.…
Brendon Stiles @BrendonStilesMD
T2. We have to figure out how to diagnose, test, and treat lung cancer better in rural communities. #NoDisparities #lcsm https://t.co/d4xxuSHFk4
#LCSM Chat @lcsmchat
RT @DevikaDasMD: @IanJPereira @BrendonStilesMD Expanding trials to real world setting - for example how to make NGS accessible in a timely…
Flemming Rasmussen @fgrazz
RT @BrendonStilesMD: T2. We need to better describe patient reported outcomes and side effects. #lcsm
Kristin Ito @KAdvocate_LCAM
@BrendonStilesMD This is HUGE! #LCSM
Bob Steele @steele_bob
Paying it Forward is one of the benefits/effects of Clinical Trial participation #lcsm
#LCSM Chat @lcsmchat
RT @fgrazz: @BrendonStilesMD T2 = better handle on genetic susceptibility, yes, but also to understand the cell env role that is part of th…
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: T2. We have to figure out how to diagnose, test, and treat lung cancer better in rural communities. #NoDisparities #l
Jean Parks @geekbabe
@BrendonStilesMD My mom died of lung cancer & I didn’t know what that meant in terms of risk till I got sick #LCSM
#LCSM Chat @lcsmchat
RT @steele_bob: Paying it Forward is one of the benefits/effects of Clinical Trial participation #lcsm
Matthew Katz, MD @subatomicdoc
RT @lgreco_ny: Yes! And how about a test that could be generally administered to catch cancer earlier? #lcsm https://t.co/4rUjlCn5YT
Brendon Stiles @BrendonStilesMD
T2. And we need to discover new targets. In many patients the “drivers” are still unknown. #lcsm https://t.co/qtA3cXNkwJ
Devika Das,MD @DevikaDasMD
@IanJPereira @BrendonStilesMD These often include assessment of real world challenges and improving processes #lcsm
Brendon Stiles @BrendonStilesMD
RT @steele_bob: Paying it Forward is one of the benefits/effects of Clinical Trial participation #lcsm
Nathan A. Pennell MD, PhD @n8pennell
RT @_ShankarSiva: It's here! SABR-COMET published in @TheLancet - https://t.co/lZmAYZ3xWK - randomised trial of ablation in oligometastast…
Timothy Craig Allen @TimAllenMDJD
#Telemedicine #Telehealth #lcsm
Jean Parks @geekbabe
RT @PercyLeeMD: @BrendonStilesMD T1: In a randomized study the standard treatment arm is what patients should receive as state of the art c…
#LCSM Chat @lcsmchat
RT @geekbabe: @BrendonStilesMD My mom died of lung cancer & I didn’t know what that meant in terms of risk till I got sick #LCSM
Laronica Conway @louisianagirl91
RT @steele_bob: Paying it Forward is one of the benefits/effects of Clinical Trial participation #lcsm
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: T2. And we need to discover new targets. In many patients the “drivers” are still unknown. #lcsm https://t.co/qtA3cX…
Jean Parks @geekbabe
RT @NarjustDuma: @BrendonStilesMD T2: I'm an advocate for including ALL patients in clinical trials. We still have knowledge gaps regarding…
#LCSM Chat @lcsmchat
RT @DevikaDasMD: @IanJPereira @BrendonStilesMD These often include assessment of real world challenges and improving processes #lcsm
Brendon Stiles @BrendonStilesMD
T3 on the way.... #lcsm
Bob Steele @steele_bob
This is such a huge issue. It has impacted friends and family members...
Flemming Rasmussen @fgrazz
@BrendonStilesMD T2 - 1000 areas - so true...some of the funded areas need to be entirely new paths #lcsm
Brendon Stiles @BrendonStilesMD
T3. What can researchers do to make their work more accessible to patients and advocates? #lcsm
Matthew Katz, MD @subatomicdoc
RT @BrendonStilesMD: T2. We have to figure out how to diagnose, test, and treat lung cancer better in rural communities. #NoDisparities #l
Timothy Craig Allen @TimAllenMDJD
#DarkSideOfTheMoon #lcsm
Devika Das,MD @DevikaDasMD
RT @BrendonStilesMD: T2. And we need to discover new targets. In many patients the “drivers” are still unknown. #lcsm https://t.co/qtA3cX…
#LCSM Chat @lcsmchat
RT @fgrazz: @BrendonStilesMD T2 - 1000 areas - so true...some of the funded areas need to be entirely new paths #lcsm
Devika Das,MD @DevikaDasMD
RT @steele_bob: Paying it Forward is one of the benefits/effects of Clinical Trial participation #lcsm
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: T3. What can researchers do to make their work more accessible to patients and advocates? #lcsm
Devika Das,MD @DevikaDasMD
RT @BrendonStilesMD: T2. We have to figure out how to diagnose, test, and treat lung cancer better in rural communities. #NoDisparities #l
Brendon Stiles @BrendonStilesMD
T3. First step is to always remember that patients are the reason we do all of this! Doctors should advocate for the diseases they treat. #lcsm
Kathleen Skambis @KathleenSkambis
RT @BrendonStilesMD: T3. What can researchers do to make their work more accessible to patients and advocates? #lcsm
MaryAnn Brown @MARYANNBROWNMFT
RT @n8pennell: Yes it will be nice to have option of pembro for some pts with PDL1 >1% but for MOST of these NSCLC pts chemo+pembro is stil…
Ageya Achili Diglihi @FriendsOfPipe
RT @BrendonStilesMD: T2. We have to figure out how to diagnose, test, and treat lung cancer better in rural communities. #NoDisparities #l
Matthew Katz, MD @subatomicdoc
@BrendonStilesMD T2. I agree. We need to do a better job meeting the needs of all patients #lcsm
Jean Parks @geekbabe
@steele_bob Knowing the researchers get info from all the blood they take from me to help others is an honor #LCSM
Matthew Katz, MD @subatomicdoc
RT @BrendonStilesMD: T3. What can researchers do to make their work more accessible to patients and advocates? #lcsm
Kristin Ito @KAdvocate_LCAM
@BrendonStilesMD Create digestible summary slides whenever they present at conferences! #LCSM
Brendon Stiles @BrendonStilesMD
T3. Researchers should join Twitter or other #SoMe platforms. Share your work. Explain it. Tell us why it is important. #lcsm
Timothy Craig Allen @TimAllenMDJD
#PatientsFirst #lcsm
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: T3. First step is to always remember that patients are the reason we do all of this! Doctors should advocate for the…
Ian Pereira @IanJPereira
RT @BrendonStilesMD: T2. We also need to understand financial toxicity of cancer care today and how that impacts patients and caregivers.…
#LCSM Chat @lcsmchat
RT @subatomicdoc: @BrendonStilesMD T2. I agree. We need to do a better job meeting the needs of all patients #lcsm
Aparna Hegde, MD @notahedge
T2: Biomarkers for screening, risk stratification in adjuvant setting, for use of IO and predicting iRAEs. So much to do. Need more funding and collaborative work. #lcsm
Brendon Stiles @BrendonStilesMD
@KAdvocate_LCAM This is key! #lcsm
Adam Wolfe, MD, PhD @wolfe1324
RT @_ShankarSiva: It's here! SABR-COMET published in @TheLancet - https://t.co/lZmAYZ3xWK - randomised trial of ablation in oligometastast…
Dr. Miriam Knoll @MKnoll_MD
RT @BrendonStilesMD: In this week’s chat we hope to explore why research matters for #LungCancer patients and how to learn more about it. #…
Bob Steele @steele_bob
RT @notahedge: T2: Biomarkers for screening, risk stratification in adjuvant setting, for use of IO and predicting iRAEs. So much to do. Ne…
#LCSM Chat @lcsmchat
RT @KAdvocate_LCAM: @BrendonStilesMD Create digestible summary slides whenever they present at conferences! #LCSM
Current Oncology @CurrentOncology
Canadian consensus: oligoprogressive, pseudoprogressive, and oligometastatic non-small-cell lung cancer https://t.co/fhQkiXTIqq #nsclc #lcsm
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: T3. Researchers should join Twitter or other #SoMe platforms. Share your work. Explain it. Tell us why it is impor…
Laronica Conway @louisianagirl91
RT @BrendonStilesMD: T3. Researchers should join Twitter or other #SoMe platforms. Share your work. Explain it. Tell us why it is impor…
#LCSM Chat @lcsmchat
RT @notahedge: T2: Biomarkers for screening, risk stratification in adjuvant setting, for use of IO and predicting iRAEs. So much to do. Ne…
Brendon Stiles @BrendonStilesMD
T3. I love this from @SurvivorNetTeam. Jim Allison explaining immunotherapy for patients. https://t.co/s5uT7NMTRw If a Nobel Prize winner can take the time, why can’t we all? #lcsm
Bob Steele @steele_bob
RT @BrendonStilesMD: T3. I love this from @SurvivorNetTeam. Jim Allison explaining immunotherapy for patients. https://t.co/s5uT7NMTRw…
Andrew Chapman @andrewchap361
RT @maryam_lustberg: Important but easy survey #gerionc #asco https://t.co/G6lIzopXN6
Dr Samer Al-Bothaigi @SalemSamer
T3 Use open access journals Use social media #some Use hashtags #lcsm
Jean Parks @geekbabe
So many patients are afraid of even simple clinical trials, even blood draw studies #LCSM
Laura Greco @lgreco_ny
So important in lung cancer in particular, as there are too few survivors, and many too sick (or too stigmatized) to really make a dent in advocacy need. #lcsm
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: T3. I love this from @SurvivorNetTeam. Jim Allison explaining immunotherapy for patients. https://t.co/s5uT7NMTRw…
Brendon Stiles @BrendonStilesMD
T3. For scientific manuscripts, visual abstracts are awesome and easy to disseminate. #lcsm https://t.co/Z9Ld0yEKok
Jean Parks @geekbabe
RT @BrendonStilesMD: T2. We have to figure out how to diagnose, test, and treat lung cancer better in rural communities. #NoDisparities #l
Samuel Chao @SamuelChaoMD
RT @JAMAOnc: BEWARE of high risk of combination of anti-angiogenic agents w SBRT to “ultra-central” chest tumors abutting proximal bronchia…
Dr Samer Al-Bothaigi @SalemSamer
RT @BrendonStilesMD: T3. I love this from @SurvivorNetTeam. Jim Allison explaining immunotherapy for patients. https://t.co/s5uT7NMTRw…
Jean Parks @geekbabe
RT @BrendonStilesMD: T2. We also need to understand financial toxicity of cancer care today and how that impacts patients and caregivers.…
Brendon Stiles @BrendonStilesMD
T3. Bring patients to your labs or to research days. #lcsm
Dr Samer Al-Bothaigi @SalemSamer
RT @BrendonStilesMD: T3. Researchers should join Twitter or other #SoMe platforms. Share your work. Explain it. Tell us why it is impor…
Brendon Stiles @BrendonStilesMD
@geekbabe This is a failure on researchers part! #lcsm
Kathleen Skambis @KathleenSkambis
T3. In addition to costs of treatment, trial costs of note to patients include simple things, like parking costs. #lcsm
Ian Pereira @IanJPereira
RT @BrendonStilesMD: T1. Voters want more research! Tell your elected representatives. From @AACR survey. #lcsm https://t.co/Xotv5CRKqy
Brendon Stiles @BrendonStilesMD
T3. When we had a #FreeToBreathe @lcrf_org lab tour, both patients and researchers learned from each other! #lcsm https://t.co/BAQmFrvxIn
Kristin Ito @KAdvocate_LCAM
@BrendonStilesMD Also...think about including patient advocates in review process for patient related surveys. #LCSM
Laura Greco @lgreco_ny
t3 how about making scientific articles actually available online instead of through paywall? #lcsm
#LCSM Chat @lcsmchat
RT @lgreco_ny: So important in lung cancer in particular, as there are too few survivors, and many too sick (or too stigmatized) to really…
Jean Parks @geekbabe
@BrendonStilesMD Yeah, I’m still working but at greatly reduced income. Cancer costs $, energy & lives #LCSM
Devika Das,MD @DevikaDasMD
@BrendonStilesMD @lcsmchat T3 Present unbiased opinions via social media ( free of conflict ) , availability of experts for second opinions via telemedicine #lcsm
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: T3. For scientific manuscripts, visual abstracts are awesome and easy to disseminate. #lcsm https://t.co/Z9Ld0yEKok
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: T3. Bring patients to your labs or to research days. #lcsm
Brendon Stiles @BrendonStilesMD
T3. This is a great video by the way – how patients help researchers and why you need to Make Noise! #lcsm
Flemming Rasmussen @fgrazz
@BrendonStilesMD T3 - means for better access to research/researchers. Change the reward structure & secrecy to openness/collaboration #lcsm
Devika Das,MD @DevikaDasMD
RT @KAdvocate_LCAM: @BrendonStilesMD Also...think about including patient advocates in review process for patient related surveys. #LCSM
#LCSM Chat @lcsmchat
RT @KathleenSkambis: T3. In addition to costs of treatment, trial costs of note to patients include simple things, like parking costs. #lc
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: T3. When we had a #FreeToBreathe @lcrf_org lab tour, both patients and researchers learned from each other! #lcsm ht…
Denise Cutlip @dennycee
Education. I still see pts who believe clinical trials are only last resort. Concept of chemo naive not in radar. #lcsm
#LCSM Chat @lcsmchat
RT @KAdvocate_LCAM: @BrendonStilesMD Also...think about including patient advocates in review process for patient related surveys. #LCSM
Matthew Katz, MD @subatomicdoc
@BrendonStilesMD T3. I agree for academics. It's different for generalists like me. I do try to advocate for all my patients, but it differs from more specialized oncology professionals. It still may be disease-specific but different strategies for advocacy #lcsm
#LCSM Chat @lcsmchat
RT @lgreco_ny: t3 how about making scientific articles actually available online instead of through paywall? #lcsm
Bob Steele @steele_bob
RT @BrendonStilesMD: T3. For scientific manuscripts, visual abstracts are awesome and easy to disseminate. #lcsm https://t.co/Z9Ld0yEKok
Brendon Stiles @BrendonStilesMD
T3. I love it when groups - @lcrf_org, @LUNGevity, @theALCF, @lcaorg – bring patients, advocates, and researchers together. #lcsm
#LCSM Chat @lcsmchat
RT @DevikaDasMD: @BrendonStilesMD @lcsmchat T3 Present unbiased opinions via social media ( free of conflict ) , availability of experts fo…
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: T3. This is a great video by the way – how patients help researchers and why you need to Make Noise! #lcsm
#LCSM Chat @lcsmchat
RT @fgrazz: @BrendonStilesMD T3 - means for better access to research/researchers. Change the reward structure & secrecy to openness/collab…
Anita Figueras @scifiknitter
Anita from northern NY joining late. A cofounder of the EGFR Resisters, which has 2 active patient-driven research projects. #LCSM
Brendon Stiles @BrendonStilesMD
@KAdvocate_LCAM More on this later! #lcsm
Narjust Duma M.D. @NarjustDumaMD
@BrendonStilesMD @lcsmchat YES! Our patients need to know what we are working on. @ivybelkins helped me make a project so much better. #lcsm
#LCSM Chat @lcsmchat
RT @dennycee: Education. I still see pts who believe clinical trials are only last resort. Concept of chemo naive not in radar. #lcsm
#LCSM Chat @lcsmchat
RT @subatomicdoc: @BrendonStilesMD T3. I agree for academics. It's different for generalists like me. I do try to advocate for all my pati…
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: T3. I love it when groups - @lcrf_org, @LUNGevity, @theALCF, @lcaorg – bring patients, advocates, and researchers tog…
Dr Samer Al-Bothaigi @SalemSamer
T3 however we want some trustworthy social media accounts that fight rumors snd dussiminate trusted and true kniwledges #SoMe4Surgery #lcsm
Anita Figueras @scifiknitter
RT @BrendonStilesMD: T3. I love this from @SurvivorNetTeam. Jim Allison explaining immunotherapy for patients. https://t.co/s5uT7NMTRw…
Laura Greco @lgreco_ny
t3 Fund scholarships so patients can go to medical conferences. Getting a scholarship can feel like winning the lotto because it is so rare. #lcsm
Brendon Stiles @BrendonStilesMD
T3. Pushing for open access publication is key. Journals could do better sharing content. From @PLOSONE https://t.co/We2J5mqJe8 #lcsm
Aparna Hegde, MD @notahedge
T3: so much can be done. 1.Share your work on #SoMe 2.Engage patient advocates when designing trials. 3.Large professional organizations should make conferences more accessible to patients and caregivers. 4.Important papers behind paywalls- this one is the toughest. #lcsm
Dr Samer Al-Bothaigi @SalemSamer
RT @BrendonStilesMD: T3. For scientific manuscripts, visual abstracts are awesome and easy to disseminate. #lcsm https://t.co/Z9Ld0yEKok
#LCSM Chat @lcsmchat
RT @NarjustDuma: @BrendonStilesMD @lcsmchat YES! Our patients need to know what we are working on. @ivybelkins helped me make a project…
Kristin Ito @KAdvocate_LCAM
@BrendonStilesMD @lcrf_org @LUNGevity @TheALCF @LCAorg Yes! Each group brings a unique expertise! #LCSM
Kimberley H Geissler @khgeissler
@lgreco_ny Many researchers happy to share if you email them for a copy. Researchers, respond to these requests!! #lcsm
Eden Lake @EdenLake
RT @BrendonStilesMD: T3. I love this from @SurvivorNetTeam. Jim Allison explaining immunotherapy for patients. https://t.co/s5uT7NMTRw…
Brendon Stiles @BrendonStilesMD
@SalemSamer We definitely need a strong voice in this space. #lcsm
Devika Das,MD @DevikaDasMD
RT @lgreco_ny: t3 how about making scientific articles actually available online instead of through paywall? #lcsm
#LCSM Chat @lcsmchat
RT @lgreco_ny: t3 Fund scholarships so patients can go to medical conferences. Getting a scholarship can feel like winning the lotto becau…
Flemming Rasmussen @fgrazz
@BrendonStilesMD that is a great example #lcsm
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: T3. Pushing for open access publication is key. Journals could do better sharing content. From @PLOSONE https://t.c…
Eden Lake @EdenLake
Late to the party #lcsm but catching up!
#LCSM Chat @lcsmchat
RT @notahedge: T3: so much can be done. 1.Share your work on #SoMe 2.Engage patient advocates when designing trials. 3.Large professional…
Jean Parks @geekbabe
@BrendonStilesMD @MGHCancerCenter The tour was amazing! I even met Dr Alice Shaw #LCSM https://t.co/8oVln1zn7c
#LCSM Chat @lcsmchat
RT @khgeissler: @lgreco_ny Many researchers happy to share if you email them for a copy. Researchers, respond to these requests!! #lcsm
Matthew Katz, MD @subatomicdoc
RT @notahedge: T3: so much can be done. 1.Share your work on #SoMe 2.Engage patient advocates when designing trials. 3.Large professional…
Dr Samer Al-Bothaigi @SalemSamer
RT @BrendonStilesMD: @SalemSamer We definitely need a strong voice in this space. #lcsm
#LCSM Chat @lcsmchat
RT @SalemSamer: T3 however we want some trustworthy social media accounts that fight rumors snd dussiminate trusted and true kniwledges #S
Devika Das,MD @DevikaDasMD
RT @lgreco_ny: t3 Fund scholarships so patients can go to medical conferences. Getting a scholarship can feel like winning the lotto becau…
Narjust Duma M.D. @NarjustDumaMD
@BrendonStilesMD @lcsmchat T3: Involve patients and families in our research. Before the project starts, during and after. Their input is invaluable! #LCSM
Brendon Stiles @BrendonStilesMD
@lgreco_ny Yes!From @PLOSONE https://t.co/We2J5mqJe8 #lcsm
Laura Greco @lgreco_ny
Involve patients in decisions on what research to fund, even internally. #lcsm
Bob Steele @steele_bob
Absolutely agree Laura! This is a high priority issue!
Ian Pereira @IanJPereira
RT @TimAllenMDJD: #Telemedicine #Telehealth #lcsm https://t.co/QEZniMfD6U
#LCSM Chat @lcsmchat
RT @NarjustDuma: @BrendonStilesMD @lcsmchat T3: Involve patients and families in our research. Before the project starts, during and afte…
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: @lgreco_ny Yes!From @PLOSONE https://t.co/We2J5mqJe8 #lcsm
#LCSM Chat @lcsmchat
RT @lgreco_ny: Involve patients in decisions on what research to fund, even internally. #lcsm https://t.co/utxNTy8Xbf
Brendon Stiles @BrendonStilesMD
@khgeissler @lgreco_ny This is definitely true. Don't hesitate to ask and also ask what they think is important about the research! #lcsm
Kathleen Skambis @KathleenSkambis
T3: lawyers have pubs that publish annual surveys of important cases in key areas. Do researchers/oncologists do this? If so, help make them accessible to patients. #lcsm
Ian Pereira @IanJPereira
@TimAllenMDJD And improve stickiness to follow-up/surveillance. #lcsm T2
Christine Qiong Wu @wi_qiong
@lgreco_ny Agree. #LCSM
Laura Greco @lgreco_ny
If you can find their email address....and many patients are very hesitant to email a doctor. #lcsm
Tim Kruser @TimothyKruserMD
RT @_ShankarSiva: It's here! SABR-COMET published in @TheLancet - https://t.co/lZmAYZ3xWK - randomised trial of ablation in oligometastast…
Brendon Stiles @BrendonStilesMD
@lgreco_ny My sense is that we are getting better at this. But more to do. #lcsm
Eden Lake @EdenLake
RT @BrendonStilesMD: T2. We need to figure out who is at risk for lung cancer, particularly among never smokers. Data from us @WeillCornel
Dr Samer Al-Bothaigi @SalemSamer
T3 consider how social media can fight smoking This only can do a lot about lung cancer #lcsm
Eden Lake @EdenLake
RT @BrendonStilesMD: T2. And we need to discover new targets. In many patients the “drivers” are still unknown. #lcsm https://t.co/qtA3cX…
Eden Lake @EdenLake
RT @BrendonStilesMD: T3. What can researchers do to make their work more accessible to patients and advocates? #lcsm
Anita Figueras @scifiknitter
@KAdvocate_LCAM @BrendonStilesMD Include patients in the design of surveys, not just in the review. We can write valid and understandable questions. #lcsm
Laura Greco @lgreco_ny
RT @NarjustDuma: @BrendonStilesMD @lcsmchat T3: Involve patients and families in our research. Before the project starts, during and afte…
Anita Figueras @scifiknitter
RT @lgreco_ny: t3 how about making scientific articles actually available online instead of through paywall? #lcsm
Eden Lake @EdenLake
RT @BrendonStilesMD: T2. We also need to understand financial toxicity of cancer care today and how that impacts patients and caregivers.…
Geoff Hugo @gdhugo
@BrendonStilesMD T3. Listen to them. Best part of our dept. retreat is the patient invited to share their experience each year. Helps us non-physicians prioritize and focus our work on what’s important to the patient. #lcsm
Christine Qiong Wu @wi_qiong
@BrendonStilesMD @PLOSONE Agree. #LCSM
Brendon Stiles @BrendonStilesMD
@EdenLake Thanks for being here! #lcsm
Virginia M. Byrne @VirginiaMByrne
#LCSM
Aparna Hegde, MD @notahedge
RT @scifiknitter: @KAdvocate_LCAM @BrendonStilesMD Include patients in the design of surveys, not just in the review. We can write valid an…
#LCSM Chat @lcsmchat
RT @KathleenSkambis: T3: lawyers have pubs that publish annual surveys of important cases in key areas. Do researchers/oncologists do this?…
Eden Lake @EdenLake
RT @BrendonStilesMD: T1. That is how we got from platinum based chemo for all to this….(from @JordiRemon) #lcsm https://t.co/nLAaZc31C5
#LCSM Chat @lcsmchat
RT @IanJPereira: @TimAllenMDJD And improve stickiness to follow-up/surveillance. #lcsm T2
Jean Parks @geekbabe
Lung cancer patients... we do matter! Research is vital #LCSM https://t.co/IL7xVEAzM8
Kristin Ito @KAdvocate_LCAM
@scifiknitter @BrendonStilesMD Absolutely agree! #LCSM
Ian Pereira @IanJPereira
T2 - more creative ways to fund more studies, including in radiation treatment for #LungCancer. #RTDrugCombo? #lcsm #RadOnc
#LCSM Chat @lcsmchat
RT @lgreco_ny: If you can find their email address....and many patients are very hesitant to email a doctor. #lcsm https://t.co/Zu1yYGeA3q
Anita Figueras @scifiknitter
RT @dennycee: Education. I still see pts who believe clinical trials are only last resort. Concept of chemo naive not in radar. #lcsm
#LCSM Chat @lcsmchat
RT @scifiknitter: @KAdvocate_LCAM @BrendonStilesMD Include patients in the design of surveys, not just in the review. We can write valid an…
#LCSM Chat @lcsmchat
RT @gdhugo: @BrendonStilesMD T3. Listen to them. Best part of our dept. retreat is the patient invited to share their experience each year.…
Laura Greco @lgreco_ny
Yes! All of this and more! #lcsm
Matthew Katz, MD @subatomicdoc
RT @gdhugo: @BrendonStilesMD T3. Listen to them. Best part of our dept. retreat is the patient invited to share their experience each year.…
Brendon Stiles @BrendonStilesMD
Rolling onto T4 in another few minutes... #lcsm
Dr Samer Al-Bothaigi @SalemSamer
T3 doctors and patients can cooperate to fight smoking by using social media #lcsm
Jean Parks @geekbabe
RT @IanJPereira: T2 - more creative ways to fund more studies, including in radiation treatment for #LungCancer. #RTDrugCombo? #lcsm #RadOnc
#LCSM Chat @lcsmchat
RT @IanJPereira: T2 - more creative ways to fund more studies, including in radiation treatment for #LungCancer. #RTDrugCombo? #lcsm #RadOnc
#LCSM Chat @lcsmchat
RT @lgreco_ny: Yes! All of this and more! #lcsm https://t.co/aoL8N76Bdd
Kimberley H Geissler @khgeissler
@lgreco_ny Agree on all points, although generally corresponding author's email is listed with the abstract so may be easier to find. (This is obviously a bandaid, not a good solution to the problem of paywalled research!) #lcsm
Jean Parks @geekbabe
RT @gdhugo: @BrendonStilesMD T3. Listen to them. Best part of our dept. retreat is the patient invited to share their experience each year.…
Jean Parks @geekbabe
RT @scifiknitter: @KAdvocate_LCAM @BrendonStilesMD Include patients in the design of surveys, not just in the review. We can write valid an…
Flemming Rasmussen @fgrazz
@lgreco_ny too true (open access would assist greatly) but you'd be surprised at what is accessible through NCBI and researchgate... #lcsm
Jean Parks @geekbabe
RT @lgreco_ny: If you can find their email address....and many patients are very hesitant to email a doctor. #lcsm https://t.co/Zu1yYGeA3q
Aparna Hegde, MD @notahedge
RT @BrendonStilesMD: T3. I love it when groups - @lcrf_org, @LUNGevity, @theALCF, @lcaorg – bring patients, advocates, and researchers tog…
Dr. Jennifer McQuade @mcquadeMDLAc
Very important study showing benefit of Stereotactic radioablation in oligometastatic cancer. Congrats to the investigators on conducting a randomized trial to address this question!
Bob Steele @steele_bob
RT @khgeissler: @lgreco_ny Agree on all points, although generally corresponding author's email is listed with the abstract so may be easie…
Kristin Ito @KAdvocate_LCAM
@wi_qiong @BrendonStilesMD @PLOSONE IASLC offers complimentary membership to patients/survivors and caregivers, which provides (free) online access to the JTO. #LCSM
Anita Figueras @scifiknitter
RT @lgreco_ny: Yes! All of this and more! #lcsm https://t.co/aoL8N76Bdd
Aparna Hegde, MD @notahedge
RT @KAdvocate_LCAM: @wi_qiong @BrendonStilesMD @PLOSONE IASLC offers complimentary membership to patients/survivors and caregivers, which p…
DrJoeBovi @DrJoeBovi
RT @_ShankarSiva: It's here! SABR-COMET published in @TheLancet - https://t.co/lZmAYZ3xWK - randomised trial of ablation in oligometastast…
Bob Steele @steele_bob
RT @KAdvocate_LCAM: @wi_qiong @BrendonStilesMD @PLOSONE IASLC offers complimentary membership to patients/survivors and caregivers, which p…
Brendon Stiles @BrendonStilesMD
T4. What is the @IASLC STARS program and why are programs that train patients and advocates important? #lcsm
Timothy Craig Allen @TimAllenMDJD
RT @KAdvocate_LCAM: @wi_qiong @BrendonStilesMD @PLOSONE IASLC offers complimentary membership to patients/survivors and caregivers, which p…
#LCSM Chat @lcsmchat
RT @khgeissler: @lgreco_ny Agree on all points, although generally corresponding author's email is listed with the abstract so may be easie…
#LCSM Chat @lcsmchat
RT @fgrazz: @lgreco_ny too true (open access would assist greatly) but you'd be surprised at what is accessible through NCBI and researchga…
OncLive.com @OncLive
PROs according to PD-L1 expression did not show clinically meaningful differences in QoL with either durvalumab or placebo in patients with stage III NSCLC who have not progressed following chemoradiotherapy #ELCC19 #lcsm https://t.co/335o5TDPS8
Ian Pereira @IanJPereira
@KAdvocate_LCAM @BrendonStilesMD And tweet or otherwise openly share the refined insights (e.g. on #lcsm). #OpenAccess
#LCSM Chat @lcsmchat
RT @KAdvocate_LCAM: @wi_qiong @BrendonStilesMD @PLOSONE IASLC offers complimentary membership to patients/survivors and caregivers, which p…
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: T4. What is the @IASLC STARS program and why are programs that train patients and advocates important? #lcsm
Jean Parks @geekbabe
My Oncologist says not all patients are as involved in following the science as I am, this needs to change #LCSM
Ian Pereira @IanJPereira
RT @BrendonStilesMD: T3. Researchers should join Twitter or other #SoMe platforms. Share your work. Explain it. Tell us why it is impor…
Brendon Stiles @BrendonStilesMD
T4. It stands for Supportive Training for Advocates on Research and Science (STARS). Great concept, right?!?! #lcsm
Timothy Craig Allen @TimAllenMDJD
RT @BrendonStilesMD: T4. What is the @IASLC STARS program and why are programs that train patients and advocates important? #lcsm
Jean Parks @geekbabe
RT @NarjustDuma: @BrendonStilesMD @lcsmchat T3: Involve patients and families in our research. Before the project starts, during and afte…
Laura Greco @lgreco_ny
@KAdvocate_LCAM @wi_qiong @BrendonStilesMD @PLOSONE @IASLC really is a leader in this regard! #lcsm
Matthew Steliga MD @SteligaMD
t3: We have a research open house type event @uamscancer for community supporters- where researchers have posters but also lay summaries with each one. It’s really well received. A lay summary of key findings can demystify the research and open doors for understanding. #LCSM
Dr Samer Al-Bothaigi @SalemSamer
T3 I luv the passion of lung cancer patients that mk them active and share this chat I respect you #lcsm
Brendon Stiles @BrendonStilesMD
T4. Here is a great link describing the program. https://t.co/pdvLflndTr #lcsm
Bob Steele @steele_bob
RT @SteligaMD: t3: We have a research open house type event @uamscancer for community supporters- where researchers have posters but also l…
Timothy Craig Allen @TimAllenMDJD
RT @SteligaMD: t3: We have a research open house type event @uamscancer for community supporters- where researchers have posters but also l…
#LCSM Chat @lcsmchat
RT @IanJPereira: @KAdvocate_LCAM @BrendonStilesMD And tweet or otherwise openly share the refined insights (e.g. on #lcsm). #OpenAccess
Matthew Katz, MD @subatomicdoc
RT @IanJPereira: T2 - more creative ways to fund more studies, including in radiation treatment for #LungCancer. #RTDrugCombo? #lcsm #RadOnc
Aparna Hegde, MD @notahedge
RT @SteligaMD: t3: We have a research open house type event @uamscancer for community supporters- where researchers have posters but also l…
Eden Lake @EdenLake
RT @geekbabe: My Oncologist says not all patients are as involved in following the science as I am, this needs to change #LCSM
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: T4. It stands for Supportive Training for Advocates on Research and Science (STARS). Great concept, right?!?! #lcsm
Timothy Craig Allen @TimAllenMDJD
RT @BrendonStilesMD: T4. It stands for Supportive Training for Advocates on Research and Science (STARS). Great concept, right?!?! #lcsm
Jean Parks @geekbabe
RT @SteligaMD: t3: We have a research open house type event @uamscancer for community supporters- where researchers have posters but also l…
Bob Steele @steele_bob
RT @BrendonStilesMD: T4. Here is a great link describing the program. https://t.co/pdvLflndTr #lcsm
Jean Parks @geekbabe
RT @BrendonStilesMD: T4. Here is a great link describing the program. https://t.co/pdvLflndTr #lcsm
Brendon Stiles @BrendonStilesMD
@lgreco_ny T4. I give lots of credit to @iaslc for recognizing the need to better train advocates and patients on research and science! #lcsm
Dr Samer Al-Bothaigi @SalemSamer
RT @geekbabe: My Oncologist says not all patients are as involved in following the science as I am, this needs to change #LCSM
Liz Johnson @wired4story
@notahedge Yes! This precisely! #lcsm #bcsm
Kristin Ito @KAdvocate_LCAM
@BrendonStilesMD @IASLC Many patients are eager to learn beyond their diagnosis and advocate for the lung cancer community as a whole! #LCSM
Brendon Stiles @BrendonStilesMD
T4. Some goals: Educate about scientific process and how to read and interpret research articles. #lcsm
Timothy Craig Allen @TimAllenMDJD
Absolutely #lcsm
Anita Figueras @scifiknitter
RT @BrendonStilesMD: @lgreco_ny T4. I give lots of credit to @iaslc for recognizing the need to better train advocates and patients on res…
#LCSM Chat @lcsmchat
RT @lgreco_ny: @KAdvocate_LCAM @wi_qiong @BrendonStilesMD @PLOSONE @IASLC really is a leader in this regard! #lcsm
Mersiha Hadziahmetovic MD DABR @MHadziMD
RT @_ShankarSiva: It's here! SABR-COMET published in @TheLancet - https://t.co/lZmAYZ3xWK - randomised trial of ablation in oligometastast…
Virginia M. Byrne @VirginiaMByrne
T3 #lcsm I just had the honor of touring Aaron Hata's lab at MGH. My eyes were opened!
Kristin Ito @KAdvocate_LCAM
RT @lgreco_ny: @KAdvocate_LCAM @wi_qiong @BrendonStilesMD @PLOSONE @IASLC really is a leader in this regard! #lcsm
#LCSM Chat @lcsmchat
RT @SteligaMD: t3: We have a research open house type event @uamscancer for community supporters- where researchers have posters but also l…
Brendon Stiles @BrendonStilesMD
T4. Goal: Teaching patients/advocates to communicate importance of lung cancer science and research. #lcsm
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: T4. Here is a great link describing the program. https://t.co/pdvLflndTr #lcsm
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: @lgreco_ny T4. I give lots of credit to @iaslc for recognizing the need to better train advocates and patients on res…
Brendon Stiles @BrendonStilesMD
T4. Important because we HAVE to have most important stakeholders – PATIENTS – at the table when making research decisions. #lcsm
#LCSM Chat @lcsmchat
RT @KAdvocate_LCAM: @BrendonStilesMD @IASLC Many patients are eager to learn beyond their diagnosis and advocate for the lung cancer commun…
Aparna Hegde, MD @notahedge
@IASLC STAR program for patient advocates. #lcsm
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: T4. Some goals: Educate about scientific process and how to read and interpret research articles. #lcsm
Timothy Craig Allen @TimAllenMDJD
RT @BrendonStilesMD: T4. Goal: Teaching patients/advocates to communicate importance of lung cancer science and research. #lcsm
Eden Lake @EdenLake
RT @BrendonStilesMD: T4. Some goals: Educate about scientific process and how to read and interpret research articles. #lcsm
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: T4. Goal: Teaching patients/advocates to communicate importance of lung cancer science and research. #lcsm
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: T4. Important because we HAVE to have most important stakeholders – PATIENTS – at the table when making research deci…
Anita Figueras @scifiknitter
RT @BrendonStilesMD: T4. Some goals: Educate about scientific process and how to read and interpret research articles. #lcsm
Kristin Ito @KAdvocate_LCAM
YES! YES! YES! #LCSM
Brendon Stiles @BrendonStilesMD
T4. We also need patients to tell the story of WHY and HOW research helped them. #LungCancer funding still lags behind. Has to change. #lcsm https://t.co/Y7eds6skik
Anita Figueras @scifiknitter
RT @BrendonStilesMD: T4. Goal: Teaching patients/advocates to communicate importance of lung cancer science and research. #lcsm
Devika Das,MD @DevikaDasMD
RT @BrendonStilesMD: T4. Here is a great link describing the program. https://t.co/pdvLflndTr #lcsm
Anita Figueras @scifiknitter
RT @BrendonStilesMD: T4. Important because we HAVE to have most important stakeholders – PATIENTS – at the table when making research deci…
Dr Samer Al-Bothaigi @SalemSamer
RT @SalemSamer: T3 however we want some trustworthy social media accounts that fight rumors snd dussiminate trusted and true kniwledges #S
Timothy Craig Allen @TimAllenMDJD
RT @BrendonStilesMD: T4. We also need patients to tell the story of WHY and HOW research helped them. #LungCancer funding still lags behi…
Arthur sharp @Arthurs19562936
RT @Merck: Each day, Dr. Cathy Pietanza is #InventingForLife and helping to improve the outlook for #lungcancer patients: https://t.co/4leT…
Efraín J. Sánchez Angarita @efrasanchez
RT @OncLive: BREAKING: Dr. Anna Farago on the @US_FDA Approval of Pembrolizumab for Lower PD-1 Cutoff #NSCLC #lcsm @MGHCancerCenter https:/…
Kathleen Skambis @KathleenSkambis
T4 should include discussions of how scientists view research results. Sometimes, appropriately, in ways more limited than many patients& advocates expect. #lcsm
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: T4. We also need patients to tell the story of WHY and HOW research helped them. #LungCancer funding still lags behi…
Ian Pereira @IanJPereira
@BrendonStilesMD T3: Perhaps recognize (and be recognized for) education - for peers, patients, public, and beyond. #lcsm #meded
Kristin Ito @KAdvocate_LCAM
@BrendonStilesMD The patient voice is so important to help guide research! STARS aims to build the patient voice UP! #LCSM
Brendon Stiles @BrendonStilesMD
Coming to T5. #lcsm
Eden Lake @EdenLake
Absolutely. Education means everything & particularly when those educating are informed patients. Its harder to ignore coming from us #lcsm
Jean Parks @geekbabe
@IanJPereira I have 1 stable tumor, said to the Onc, can’t you use focus radiation or freeze & surgically remove it now? I do my reading 😀 #LCSM
#LCSM Chat @lcsmchat
RT @KAdvocate_LCAM: @BrendonStilesMD The patient voice is so important to help guide research! STARS aims to build the patient voice UP! #L
#LCSM Chat @lcsmchat
RT @KathleenSkambis: T4 should include discussions of how scientists view research results. Sometimes, appropriately, in ways more limited…
Aparna Hegde, MD @notahedge
This is important in spreading awareness about research, trial participation, fund raising and design of better research. #lcsm
Anita Figueras @scifiknitter
RT @BrendonStilesMD: T4. We also need patients to tell the story of WHY and HOW research helped them. #LungCancer funding still lags behi…
#LCSM Chat @lcsmchat
RT @IanJPereira: @BrendonStilesMD T3: Perhaps recognize (and be recognized for) education - for peers, patients, public, and beyond. #lcsm
Jean Parks @geekbabe
RT @BrendonStilesMD: T3. Researchers should join Twitter or other #SoMe platforms. Share your work. Explain it. Tell us why it is impor…
Brendon Stiles @BrendonStilesMD
T5. How can patients and advocates get more involved with research?#lcsm
Christine Qiong Wu @wi_qiong
@BrendonStilesMD Agree.#lcsm
#LCSM Chat @lcsmchat
RT @EdenLake: Absolutely. Education means everything & particularly when those educating are informed patients. Its harder to ignore coming…
Devika Das,MD @DevikaDasMD
@BrendonStilesMD @lcsmchat @CoC_ACS needs to make inclusion of patient advocates on the cancer committees mandatory as required members to maintain accreditation #lcsm
Dr Samer Al-Bothaigi @SalemSamer
RT @KAdvocate_LCAM: @BrendonStilesMD The patient voice is so important to help guide research! STARS aims to build the patient voice UP! #L
#LCSM Chat @lcsmchat
RT @notahedge: This is important in spreading awareness about research, trial participation, fund raising and design of better research. #l
Brendon Stiles @BrendonStilesMD
T5. Scan the literature and ask questions. Reach out to authors, especially those on social media. They want the dialogue too. #lcsm
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: T5. How can patients and advocates get more involved with research?#lcsm
Jean Parks @geekbabe
RT @KAdvocate_LCAM: @BrendonStilesMD The patient voice is so important to help guide research! STARS aims to build the patient voice UP! #L
Jean Parks @geekbabe
RT @BrendonStilesMD: T4. We also need patients to tell the story of WHY and HOW research helped them. #LungCancer funding still lags behi…
Timothy Craig Allen @TimAllenMDJD
RT @BrendonStilesMD: T5. How can patients and advocates get more involved with research?#lcsm
Brendon Stiles @BrendonStilesMD
T5. Several websites try to update news from the field and to put it in common language. https://t.co/0fkUOn6Xpz #lcsm
Dr Samer Al-Bothaigi @SalemSamer
RT @EdenLake: Absolutely. Education means everything & particularly when those educating are informed patients. Its harder to ignore coming…
Laura Greco @lgreco_ny
RT @DevikaDasMD: @BrendonStilesMD @lcsmchat @CoC_ACS needs to make inclusion of patient advocates on the cancer committees mandatory as re…
Ryo. Oncology @OncologyRyo
RT @Tony_Calles: Chemotherapy looks better for low bTMB based on OAK/POPLAR trial in 2nd line NSCLC #ELCC19 #LCSM #OncoAlert https://t.co/Q…
Timothy Craig Allen @TimAllenMDJD
RT @BrendonStilesMD: T5. Several websites try to update news from the field and to put it in common language. https://t.co/0fkUOn6Xpz #lc
Brendon Stiles @BrendonStilesMD
T5. @SurvivorNetTeam does a good job of keeping an eye on scientific advances and explaining them in lay terms. https://t.co/Hy924wM24j #lcsm
Virginia M. Byrne @VirginiaMByrne
#lcsm At MSKCC it's against the "rules" to email docs or nurses. I find that so backwards.
Flemming Rasmussen @fgrazz
@BrendonStilesMD Indeed...some of the targets may be already well known pathways..tackled from entirely new approaches #LCSM
#LCSM Chat @lcsmchat
RT @DevikaDasMD: @BrendonStilesMD @lcsmchat @CoC_ACS needs to make inclusion of patient advocates on the cancer committees mandatory as re…
Aparna Hegde, MD @notahedge
RT @BrendonStilesMD: T5. Scan the literature and ask questions. Reach out to authors, especially those on social media. They want the di…
Eden Lake @EdenLake
RT @lgreco_ny: Involve patients in decisions on what research to fund, even internally. #lcsm https://t.co/utxNTy8Xbf
Dr Samer Al-Bothaigi @SalemSamer
RT @BrendonStilesMD: T5. Scan the literature and ask questions. Reach out to authors, especially those on social media. They want the di…
Dr Samer Al-Bothaigi @SalemSamer
RT @BrendonStilesMD: T5. Several websites try to update news from the field and to put it in common language. https://t.co/0fkUOn6Xpz #lc
Laura Greco @lgreco_ny
RT @KAdvocate_LCAM: YES! YES! YES! #LCSM https://t.co/XO7OACfNMo
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: T5. Scan the literature and ask questions. Reach out to authors, especially those on social media. They want the di…
Brendon Stiles @BrendonStilesMD
T5. Don’t be afraid to ask researchers to describe their work in practical terms. If they can’t, it just might not be impactful! #lcsm
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: T5. Several websites try to update news from the field and to put it in common language. https://t.co/0fkUOn6Xpz #lc
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: T5. @SurvivorNetTeam does a good job of keeping an eye on scientific advances and explaining them in lay terms. http…
Anita Figueras @scifiknitter
RT @BrendonStilesMD: T5. Several websites try to update news from the field and to put it in common language. https://t.co/0fkUOn6Xpz #lc
Kathleen Skambis @KathleenSkambis
T5. Keep telling everyone you meet how interested you are in area and ask for their help. #lcsm
Brendon Stiles @BrendonStilesMD
@VirginiaMByrne Lame. #lcsm
Kristin Ito @KAdvocate_LCAM
@BrendonStilesMD @SurvivorNetTeam Thank you for sharing this! #LCSM
Geoff Hugo @gdhugo
RT @BrendonStilesMD: T5. @SurvivorNetTeam does a good job of keeping an eye on scientific advances and explaining them in lay terms. http…
#LCSM Chat @lcsmchat
RT @VirginiaMByrne: #lcsm At MSKCC it's against the "rules" to email docs or nurses. I find that so backwards. https://t.co/p6ohncwRon
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: T5. Don’t be afraid to ask researchers to describe their work in practical terms. If they can’t, it just might not b…
Radio pedia MEXICO @RadioOncopediat
RT @IanJPereira: T2 - more creative ways to fund more studies, including in radiation treatment for #LungCancer. #RTDrugCombo? #lcsm #RadOnc
#LCSM Chat @lcsmchat
RT @KathleenSkambis: T5. Keep telling everyone you meet how interested you are in area and ask for their help. #lcsm
Timothy Craig Allen @TimAllenMDJD
RT @BrendonStilesMD: T5. Don’t be afraid to ask researchers to describe their work in practical terms. If they can’t, it just might not b…
Aparna Hegde, MD @notahedge
@cancerGRACE is also an excellent resource #lcsm
Brendon Stiles @BrendonStilesMD
T5. Go to your local cancer hospital and ask what is happening in lung cancer research! Dialogue is key. #lcsm
Dr Samer Al-Bothaigi @SalemSamer
RT @BrendonStilesMD: T5. Don’t be afraid to ask researchers to describe their work in practical terms. If they can’t, it just might not b…
Brendon Stiles @BrendonStilesMD
T5. Joining local IRBs or other committees is also a great way to learn and make a difference. #lcsm
Ian Pereira @IanJPereira
@lgreco_ny Not easy to advocate for oneself, let alone others, when sick. However, supportive, accessible communities (like #lcsm) can amplify voices beyond their physical boundaries. T3
Brendon Stiles @BrendonStilesMD
@notahedge @cancerGRACE Very true! #lcsm
#LCSM Chat @lcsmchat
RT @notahedge: @cancerGRACE is also an excellent resource #lcsm
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: T5. Go to your local cancer hospital and ask what is happening in lung cancer research! Dialogue is key. #lcsm
Christine Qiong Wu @wi_qiong
@BrendonStilesMD T5, good to know.#lcsm
Brendon Stiles @BrendonStilesMD
T5. Many lung cancer organizations have committees in which patients can be involved. Yes, do advocacy and education, but ask about research too! #lcsm
Jean Parks @geekbabe
@BrendonStilesMD Every picture tells a cancer patient’s story #LCSM https://t.co/jS4T1ruZ6p
Flemming Rasmussen @fgrazz
@BrendonStilesMD T5 - this in spades...one of the hardest things is getting the right narrative in a story that connects #lcsm
Dr Samer Al-Bothaigi @SalemSamer
RT @IanJPereira: @lgreco_ny Not easy to advocate for oneself, let alone others, when sick. However, supportive, accessible communities (li…
Paula @lungcancer1964
RT @BrendonStilesMD: T2. We need to understand why so many patients develop resistance to drugs that initially work. #lcsm https://t.co/hS…
Brendon Stiles @BrendonStilesMD
T5. I love it that @ALKLungCancer (ALKPositive), @EGFRResisters, @ROS1ders and others are asking for a stake in research. #lcsm
Ian Pereira @IanJPereira
RT @BrendonStilesMD: T3. For scientific manuscripts, visual abstracts are awesome and easy to disseminate. #lcsm https://t.co/Z9Ld0yEKok
Brendon Stiles @BrendonStilesMD
Love. #lcsm https://t.co/YianVJveVv
Paula @lungcancer1964
RT @BrendonStilesMD: T2. We need to figure out who is at risk for lung cancer, particularly among never smokers. Data from us @WeillCornel
Brendon Stiles @BrendonStilesMD
Love. #lcsm https://t.co/a3qOfqa6RO
Jean Parks @geekbabe
RT @IanJPereira: @lgreco_ny Not easy to advocate for oneself, let alone others, when sick. However, supportive, accessible communities (li…
Timothy Craig Allen @TimAllenMDJD
RT @geekbabe: @BrendonStilesMD Every picture tells a cancer patient’s story #LCSM https://t.co/jS4T1ruZ6p
Brendon Stiles @BrendonStilesMD
Love. #lcsm https://t.co/SQyOjkVcBg
Laura Greco @lgreco_ny
75 Patients can get involved as reviewers for those programs that (rightly) value the patient perspective, such as @CDMRP . Then, when other organizations fail to have patients present (including lung orgs), ask, "Why not"? I guarantee you no one at the table cares more. #lcsm
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: T5. Joining local IRBs or other committees is also a great way to learn and make a difference. #lcsm
Brendon Stiles @BrendonStilesMD
T5. Every grant funding panel I have ever been on that includes a patient or advocate has been BETTER because of it. #lcsm
#LCSM Chat @lcsmchat
RT @IanJPereira: @lgreco_ny Not easy to advocate for oneself, let alone others, when sick. However, supportive, accessible communities (li…
Devika Das,MD @DevikaDasMD
@BrendonStilesMD T5 Active input in clinical trial designs, larger inclusion in panels at national meetings, advocacy in Washington for more research funding, engage other patients and caregivers to do the same #lcsm
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: T5. Many lung cancer organizations have committees in which patients can be involved. Yes, do advocacy and education…
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: T5. I love it that @ALKLungCancer (ALKPositive), @EGFRResisters, @ROS1ders and others are asking for a stake in resea…
Brendon Stiles @BrendonStilesMD
RT @fgrazz: @BrendonStilesMD T5 - this in spades...one of the hardest things is getting the right narrative in a story that connects #lcsm
Bob Steele @steele_bob
RT @BrendonStilesMD: T5. Every grant funding panel I have ever been on that includes a patient or advocate has been BETTER because of it.…
Jean Parks @geekbabe
RT @lgreco_ny: 75 Patients can get involved as reviewers for those programs that (rightly) value the patient perspective, such as @CDMRP .…
#LCSM Chat @lcsmchat
RT @lgreco_ny: 75 Patients can get involved as reviewers for those programs that (rightly) value the patient perspective, such as @CDMRP .…
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: T5. Every grant funding panel I have ever been on that includes a patient or advocate has been BETTER because of it.…
#LCSM Chat @lcsmchat
RT @DevikaDasMD: @BrendonStilesMD T5 Active input in clinical trial designs, larger inclusion in panels at national meetings, advocacy in W…
Timothy Craig Allen @TimAllenMDJD
RT @lgreco_ny: 75 Patients can get involved as reviewers for those programs that (rightly) value the patient perspective, such as @CDMRP .…
Dr Samer Al-Bothaigi @SalemSamer
RT @BrendonStilesMD: Love. #lcsm https://t.co/SQyOjkVcBg
Brendon Stiles @BrendonStilesMD
T5. @cdmrp does a great job involving patients/advocates as peer reviewers. https://t.co/t01HPrn4nd #lcsm https://t.co/r20E3WlIfG
Timothy Craig Allen @TimAllenMDJD
RT @BrendonStilesMD: Love. #lcsm https://t.co/SQyOjkVcBg
Brendon Stiles @BrendonStilesMD
T5. And @AACR has an amazing Scientist-Survivor Program. https://t.co/9SRv5YSAZk #lcsm
Laura Greco @lgreco_ny
@BrendonStilesMD @ALKLungCancer @EGFRResisters t5: New additional group, @alk_fusion It's really focusing in on the concept of patients as partners. #lcsm
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: T5. @cdmrp does a great job involving patients/advocates as peer reviewers. https://t.co/t01HPrn4nd #lcsm https://t.c…
Eden Lake @EdenLake
RT @KAdvocate_LCAM: @wi_qiong @BrendonStilesMD @PLOSONE IASLC offers complimentary membership to patients/survivors and caregivers, which p…
Bob Steele @steele_bob
RT @Tony_Calles: Chemotherapy looks better for low bTMB based on OAK/POPLAR trial in 2nd line NSCLC #ELCC19 #LCSM #OncoAlert https://t.co/Q…
Matthew Katz, MD @subatomicdoc
RT @DevikaDasMD: @BrendonStilesMD T5 Active input in clinical trial designs, larger inclusion in panels at national meetings, advocacy in W…
Brendon Stiles @BrendonStilesMD
Almost time to wind the chat down. This has been an incredible discussion. #lcsm
Ian Pereira @IanJPereira
@KathleenSkambis Great point - perhaps these can be built into studies to make them more accessible (e.g. free parking slips, or #telemedicine) T3 #lcsm
Brendon Stiles @BrendonStilesMD
Please share your closing thoughts! #lcsm
Aparna Hegde, MD @notahedge
#lcsm look at these smarties presenting at #AACR19
Dr Samer Al-Bothaigi @SalemSamer
RT @BrendonStilesMD: Almost time to wind the chat down. This has been an incredible discussion. #lcsm
Amir Safavi @safaviaa
RT @BrendonStilesMD: T5. Every grant funding panel I have ever been on that includes a patient or advocate has been BETTER because of it.…
Laura Greco @lgreco_ny
RT @BrendonStilesMD: T5. @cdmrp does a great job involving patients/advocates as peer reviewers. https://t.co/t01HPrn4nd #lcsm https://t.c…
Flemming Rasmussen @fgrazz
@BrendonStilesMD T5 - re funding panels. There are not many means to get ideas fm the outside looked at, except by private investors #lcsm
Devika Das,MD @DevikaDasMD
RT @lgreco_ny: 75 Patients can get involved as reviewers for those programs that (rightly) value the patient perspective, such as @CDMRP .…
Eden Lake @EdenLake
RT @lgreco_ny: 75 Patients can get involved as reviewers for those programs that (rightly) value the patient perspective, such as @CDMRP .…
Jean Parks @geekbabe
We are husbands,wives, parents, grandparents, workers, friends.. not just cancer patients. We matter, our lives matter #LCSM
Brendon Stiles @BrendonStilesMD
#Research has to be doing something right. Whether it is research into causes and prevention, screening, or new therapeutics - we are making progress. #lcsm https://t.co/6aOAdkygsJ
Kathleen Skambis @KathleenSkambis
These chats are SO worthwhile. Thank you. #lcsm
Anita Figueras @scifiknitter
RT @BrendonStilesMD: T5. I love it that @ALKLungCancer (ALKPositive), @EGFRResisters, @ROS1ders and others are asking for a stake in resea…
Laronica Conway @louisianagirl91
RT @BrendonStilesMD: T5. Every grant funding panel I have ever been on that includes a patient or advocate has been BETTER because of it.…
Flemming Rasmussen @fgrazz
RT @KathleenSkambis: These chats are SO worthwhile. Thank you. #lcsm
Timothy Craig Allen @TimAllenMDJD
This #lcsm
Paula @lungcancer1964
RT @BrendonStilesMD: T2. We also need to understand financial toxicity of cancer care today and how that impacts patients and caregivers.…
Virginia M. Byrne @VirginiaMByrne
T5 They have the greatest stake in research!
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: T5. And @AACR has an amazing Scientist-Survivor Program. https://t.co/9SRv5YSAZk #lcsm
Brendon Stiles @BrendonStilesMD
Let's not let up. Keep #Research strong. #lcsm https://t.co/1J0Ht5JoaW
#LCSM Chat @lcsmchat
RT @lgreco_ny: @BrendonStilesMD @ALKLungCancer @EGFRResisters t5: New additional group, @alk_fusion It's really focusing in on the concept…
Matthew Katz, MD @subatomicdoc
RT @BrendonStilesMD: #Research has to be doing something right. Whether it is research into causes and prevention, screening, or new thera…
Kristin Ito @KAdvocate_LCAM
Thank you @BrendonStilesMD for hosting! To learn more about the STARS program, please visit: https://t.co/CQyycc5Z87 #LCSM #strongertogether
Bob Steele @steele_bob
RT @BrendonStilesMD: Let's not let up. Keep #Research strong. #lcsm https://t.co/1J0Ht5JoaW
Virginia M. Byrne @VirginiaMByrne
#lcsm
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: Almost time to wind the chat down. This has been an incredible discussion. #lcsm
#LCSM Chat @lcsmchat
RT @IanJPereira: @KathleenSkambis Great point - perhaps these can be built into studies to make them more accessible (e.g. free parking sli…
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: Please share your closing thoughts! #lcsm
Aparna Hegde, MD @notahedge
#AACR19 had a survivor scientist program this year. Ask these organizations how to get involved #lcsm @ivybelkins @jillfeldman4 @EGFRResisters
#LCSM Chat @lcsmchat
RT @notahedge: #lcsm look at these smarties presenting at #AACR19 https://t.co/NxIr5NonyV
#LCSM Chat @lcsmchat
RT @fgrazz: @BrendonStilesMD T5 - re funding panels. There are not many means to get ideas fm the outside looked at, except by private inv…
#LCSM Chat @lcsmchat
RT @geekbabe: We are husbands,wives, parents, grandparents, workers, friends.. not just cancer patients. We matter, our lives matter #LCSM
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: #Research has to be doing something right. Whether it is research into causes and prevention, screening, or new thera…
Dr Samer Al-Bothaigi @SalemSamer
Thanks #some social media @twitter that allowed me to share this chat with Even though i am far away from USA See you soon Peace upon you From the land of war Yemen #lcsm
Laura A. Fiorenza @LauraAFiorenza
A truly educational, engaging presentation and discussion bringing the MD/NP/patient perspectives on EGFR+ lung cancer - thank you for sharing your stories. @EGFRResisters #ONSCongress #lcsm
Brendon Stiles @BrendonStilesMD
Another way to think about it! #lcsm https://t.co/Raxa5FOAWO
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: Let's not let up. Keep #Research strong. #lcsm https://t.co/1J0Ht5JoaW
#LCSM Chat @lcsmchat
RT @KAdvocate_LCAM: Thank you @BrendonStilesMD for hosting! To learn more about the STARS program, please visit: https://t.co/CQyycc5Z87 #L
Eden Lake @EdenLake
RT @notahedge: #lcsm look at these smarties presenting at #AACR19 https://t.co/NxIr5NonyV
Jean Parks @geekbabe
I see so many more young people in the waiting room than ever before. Research is key to helping #LCSM
#LCSM Chat @lcsmchat
RT @VirginiaMByrne: #lcsm https://t.co/Oj5iec01Al
Denise Cutlip @dennycee
RT @lgreco_ny: @BrendonStilesMD @ALKLungCancer @EGFRResisters t5: New additional group, @alk_fusion It's really focusing in on the concept…
Peggy Dennis @peggyddennis
Sorry to join late. These chats are informative and helpful. Research Rocks! #lcsm
Anita Figueras @scifiknitter
RT @lgreco_ny: 75 Patients can get involved as reviewers for those programs that (rightly) value the patient perspective, such as @CDMRP .…
Matthias Scheffler @trnsltnl
RT @Tony_Calles: VARGADO: Nintedanib + Docetaxel in 3rd line after 2nd line Immunotherapy in NSCLC. Encouraging results from real clinical…
Timothy Craig Allen @TimAllenMDJD
Yes, thank you, @BrendonStilesMD #lcsm
#LCSM Chat @lcsmchat
RT @LauraAFiorenza: A truly educational, engaging presentation and discussion bringing the MD/NP/patient perspectives on EGFR+ lung cancer…
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: Another way to think about it! #lcsm https://t.co/Raxa5FOAWO
Brendon Stiles @BrendonStilesMD
#Research moves the needle. Without a doubt. #lcsm https://t.co/NXhOkYBW8g
Eden Lake @EdenLake
RT @BrendonStilesMD: Let's not let up. Keep #Research strong. #lcsm https://t.co/1J0Ht5JoaW
Matthew Katz, MD @subatomicdoc
@BrendonStilesMD It also means publishing/sharing negative #research findings to avoid wasting precious funding on less worthwhile hypotheses #lcsm
Paula @lungcancer1964
RT @KAdvocate_LCAM: @BrendonStilesMD Create digestible summary slides whenever they present at conferences! #LCSM
Brendon Stiles @BrendonStilesMD
Look how far we have come in lung cancer in a very short time. #lcsm https://t.co/4L7D0EhXmh
#LCSM Chat @lcsmchat
Thank you @BrendonStilesMD for another excellent moderating stint! #LCSM
Bob Steele @steele_bob
RT @BrendonStilesMD: Look how far we have come in lung cancer in a very short time. #lcsm https://t.co/4L7D0EhXmh
Matthias Scheffler @trnsltnl
RT @BrendonStilesMD: T5. I love it that @ALKLungCancer (ALKPositive), @EGFRResisters, @ROS1ders and others are asking for a stake in resea…
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: #Research moves the needle. Without a doubt. #lcsm https://t.co/NXhOkYBW8g
#LCSM Chat @lcsmchat
RT @subatomicdoc: @BrendonStilesMD It also means publishing/sharing negative #research findings to avoid wasting precious funding on less w…
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: Look how far we have come in lung cancer in a very short time. #lcsm https://t.co/4L7D0EhXmh
Timothy Craig Allen @TimAllenMDJD
#Hope #lcsm
Dr Samer Al-Bothaigi @SalemSamer
We can use social media to conduct multi-hospitals collaborative researches. From all over the world #lcsm
Jean Parks @geekbabe
Thank you for the chat... I suspect finishing my taxes will get me before my cancer does #LCSM 😀
Deb Smith 🦋🌻🦉🐢🌿 @debsmithbeach
RT @BrendonStilesMD: Let's not let up. Keep #Research strong. #lcsm https://t.co/1J0Ht5JoaW
Dr Samer Al-Bothaigi @SalemSamer
RT @BrendonStilesMD: Look how far we have come in lung cancer in a very short time. #lcsm https://t.co/4L7D0EhXmh
Brendon Stiles @BrendonStilesMD
Found this great graphic. Good summary of why patients should engage in research. #lcsm https://t.co/zOSXehQmhk
Eden Lake @EdenLake
Thank you for hosting @BrendonStilesMD! Ill be catching up on what i missed via transcript. Sorry to be absent lately, work sched is killing me. Miss my #LCSM sisters n brothers
Laura Greco @lgreco_ny
RT @subatomicdoc: @BrendonStilesMD It also means publishing/sharing negative #research findings to avoid wasting precious funding on less w…
Devika Das,MD @DevikaDasMD
RT @BrendonStilesMD: Look how far we have come in lung cancer in a very short time. #lcsm https://t.co/4L7D0EhXmh
Brendon Stiles @BrendonStilesMD
Thanks to all of the #lcsm community who joined. And BIG thanks to all of our guests tonight. Incredible turnout! #lcsm
Christine Qiong Wu @wi_qiong
@lcsmchat @BrendonStilesMD Thank you for your encouagement. #lcsm
Parneet Cheema @drcheema_cancer
RT @CurrentOncology: Canadian consensus: oligoprogressive, pseudoprogressive, and oligometastatic non-small-cell lung cancer https://t.co/f…
Matthew Katz, MD @subatomicdoc
RT @BrendonStilesMD: Look how far we have come in lung cancer in a very short time. #lcsm https://t.co/4L7D0EhXmh
Timothy Craig Allen @TimAllenMDJD
RT @BrendonStilesMD: Found this great graphic. Good summary of why patients should engage in research. #lcsm https://t.co/zOSXehQmhk
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: Found this great graphic. Good summary of why patients should engage in research. #lcsm https://t.co/zOSXehQmhk
KC Dill @kasedill
I missed this informative chat tonight. Can’t wait to look over the notes time change got me. #lcsm
Aparna Hegde, MD @notahedge
@BrendonStilesMD When I started fellowship there was only platinum doublet. The scene exploded over the past 4 years. #lcsm
Brendon Stiles @BrendonStilesMD
Thanks to everyone for participating! #lcsm
Dr Samer Al-Bothaigi @SalemSamer
RT @BrendonStilesMD: Found this great graphic. Good summary of why patients should engage in research. #lcsm https://t.co/zOSXehQmhk
Anita Figueras @scifiknitter
RT @subatomicdoc: @BrendonStilesMD It also means publishing/sharing negative #research findings to avoid wasting precious funding on less w…
Devika Das,MD @DevikaDasMD
Closing thoughts - Screening saves lives. Need more robust lung cancer screening inplemtnation and continued research to study its impact #lcsm
Parneet Cheema @drcheema_cancer
RT @PercyLeeMD: Practice changing paradigm. #sabr stereotactic ablative radiotherapy for oligometaststic disease state #lcsm #pcsm #bcsm #…
Dr Samer Al-Bothaigi @SalemSamer
RT @BrendonStilesMD: Thanks to everyone for participating! #lcsm
Paula @lungcancer1964
RT @lgreco_ny: t3 Fund scholarships so patients can go to medical conferences. Getting a scholarship can feel like winning the lotto becau…
Anita Figueras @scifiknitter
RT @BrendonStilesMD: Look how far we have come in lung cancer in a very short time. #lcsm https://t.co/4L7D0EhXmh
Bob Steele @steele_bob
This has been Par Excellence! Thanks all for the great info. Look forward to seeing you at next month's LUNG CANCER SOCIAL MEDIA Twitter Chat Session. Good night all. #lcsm
Matthew Katz, MD @subatomicdoc
RT @notahedge: #AACR19 had a survivor scientist program this year. Ask these organizations how to get involved #lcsm @ivybelkins @jillfeldm
Aparna Hegde, MD @notahedge
@BrendonStilesMD When I started fellowship there was only platinum doublet besides TKIs for NSCLC. Over 4 years, have had to learn and relearn constantly and I love it! #lcsm
Matthew Katz, MD @subatomicdoc
RT @BrendonStilesMD: Please share your closing thoughts! #lcsm
Matthew Katz, MD @subatomicdoc
RT @lgreco_ny: 75 Patients can get involved as reviewers for those programs that (rightly) value the patient perspective, such as @CDMRP .…
Amir Safavi @safaviaa
RT @BrendonStilesMD: Look how far we have come in lung cancer in a very short time. #lcsm https://t.co/4L7D0EhXmh
Amir Safavi @safaviaa
RT @KathleenSkambis: T3. In addition to costs of treatment, trial costs of note to patients include simple things, like parking costs. #lc
Bob Steele @steele_bob
RT @notahedge: @BrendonStilesMD When I started fellowship there was only platinum doublet besides TKIs for NSCLC. Over 4 years, have had to…
Brendon Stiles @BrendonStilesMD
We have come a long way from this. But research got us there. And research will take us farther. #lcsm https://t.co/Zbh1RcoKiq
Laronica Conway @louisianagirl91
Thank you for providing some really important info for patients and their caregivers! Research isn’t just for “scientists”! We all deserve to know how we can benefit from research! #researchsaveslives #lcsm
Deb Smith 🦋🌻🦉🐢🌿 @debsmithbeach
@BrendonStilesMD Thanks to you too! #LCSM
Dr. David Tom Cooke @DavidCookeMD
RT @BrendonStilesMD: Look how far we have come in lung cancer in a very short time. #lcsm https://t.co/4L7D0EhXmh
Timothy Craig Allen @TimAllenMDJD
RT @BrendonStilesMD: We have come a long way from this. But research got us there. And research will take us farther. #lcsm https://t.co…
Alex Tan @DrAlexTan
RT @_ShankarSiva: It's here! SABR-COMET published in @TheLancet - https://t.co/lZmAYZ3xWK - randomised trial of ablation in oligometastast…
Paula @lungcancer1964
RT @KAdvocate_LCAM: Thank you @BrendonStilesMD for hosting! To learn more about the STARS program, please visit: https://t.co/CQyycc5Z87 #L
Geraldine McGinty @DrGMcGinty
RT @BrendonStilesMD: T3. What can researchers do to make their work more accessible to patients and advocates? #lcsm
Aparna Hegde, MD @notahedge
Research is amazing when its meaningful, purposeful and collaborative. Let's keep it going! Thanks for hosting the chat @BrendonStilesMD @lcsmchat As always, happy to reconnect with everyone. #lcsm
Giorgos Tsaousis @g_tsaousis
RT @n8pennell: Yes it will be nice to have option of pembro for some pts with PDL1 >1% but for MOST of these NSCLC pts chemo+pembro is stil…
Brendon Stiles @BrendonStilesMD
Signing off! Thanks everyone for joining. Support #Research. Do #Research. Participate in #Research. Lives depend upon it. #lcsm https://t.co/wvjfefmFPX
Devika Das,MD @DevikaDasMD
RT @debsmithbeach: T1. I've been in 3 clinical trials so far and 2/3 have benifitted me significantly! Happy to help future patients, thril…
Geraldine McGinty @DrGMcGinty
RT @BrendonStilesMD: T2. We have to figure out how to diagnose, test, and treat lung cancer better in rural communities. #NoDisparities #l
Deb Smith 🦋🌻🦉🐢🌿 @debsmithbeach
RT @BrendonStilesMD: Signing off! Thanks everyone for joining. Support #Research. Do #Research. Participate in #Research. Lives depend u…
Geraldine McGinty @DrGMcGinty
@cjeverett @FriedbergEric @LLALO
Dr. Salazar @csalazar7
RT @APassaroMD: #ELCC19 #lcsm Dr Chu discussing MYSTIC trial based on clinical characteristics, a very interesting point of view! Age and…
Waël Hanna @wc_hanna
RT @BrendonStilesMD: Look how far we have come in lung cancer in a very short time. #lcsm https://t.co/4L7D0EhXmh
Dr. Matthew Schabath @MatthewSchabath
The latest issue of 'Science, Society, and Sports'! https://t.co/Mpjg45inQO Thanks to @RichieKimbumina @ooshdesign @CalTwomey #lcsm #lungcancer
Dhoruba Khali @DhorubaKhali
The latest After The Ribbon Daily! https://t.co/yLaOkUHqjW Thanks to @Nastyness61 @itsmorenamorena @pn8h4g7y1fo #hiv #lcsm
Christine Qiong Wu @wi_qiong
@notahedge @BrendonStilesMD @lcsmchat Well said. #lcsm
Geraldine McGinty @DrGMcGinty
RT @BrendonStilesMD: T3. Bring patients to your labs or to research days. #lcsm
Geraldine McGinty @DrGMcGinty
Or to tumor board like @SamirPatel_MD does
Matthew Katz, MD @subatomicdoc
@BrendonStilesMD Thanks for moderating #LCSM chat!
Diana Jaimes @DianaJa21318387
RT @FDAOncology: FDA expands pembrolizumab indication for first-line treatment of non-small cell lung cancer (TPS ≥1%). #NSCLC #lcsm https:…
Matthias Scheffler @trnsltnl
RT @n8pennell: Yes it will be nice to have option of pembro for some pts with PDL1 >1% but for MOST of these NSCLC pts chemo+pembro is stil…
Lillian Leigh @ProjectBreath
I certainly feel like I'm a part of the small but growing pool of blue. #WhyResearchMatters #LCSM
Henning Willers, MD @HenningWillers
RT @_ShankarSiva: It's here! SABR-COMET published in @TheLancet - https://t.co/lZmAYZ3xWK - randomised trial of ablation in oligometastast…
Michelle Hershman @MichelleHersh11
RT @ivybelkins: @cancerGRACE Targeted Therapies Forum is starting right now with this awesome faculty! If you’re not in Philly, please go t…
Ian Pereira @IanJPereira
@notahedge Group in Europe is working on the #paywalls for publicly-funded research (https://t.co/IF4WzGZC0S), and more #OpenAccess manuscripts are on PubMed, but still a ways to go. #lcsm T3
Ian Pereira @IanJPereira
@BrendonStilesMD Thanks Dr. Stiles for organizing, and everyone in #lcsm for the great chat. Cheers from Toronto.
Jean Parks @geekbabe
RT @BrendonStilesMD: Signing off! Thanks everyone for joining. Support #Research. Do #Research. Participate in #Research. Lives depend u…
SiKiii @egogem7
RT @PercyLeeMD: Practice changing paradigm. #sabr stereotactic ablative radiotherapy for oligometaststic disease state #lcsm #pcsm #bcsm #…
Ray Manneh Kopp @raymanneh
RT @_ShankarSiva: It's here! SABR-COMET published in @TheLancet - https://t.co/lZmAYZ3xWK - randomised trial of ablation in oligometastast…
Jean Parks @geekbabe
RT @BrendonStilesMD: Found this great graphic. Good summary of why patients should engage in research. #lcsm https://t.co/zOSXehQmhk
Brandon A Dyer, MD @BrandonADyer
RT @_ShankarSiva: It's here! SABR-COMET published in @TheLancet - https://t.co/lZmAYZ3xWK - randomised trial of ablation in oligometastast…
Matthias Scheffler @trnsltnl
CTX combi still preferable if PD-L1 <50%, no doubt. But at least justification that Pembro mono doesn‘t harm in these patients!@StephenVLiu @TonyMok9 #LCSM #ELCC19
Cristobal Alvarado @CrisAlvaradoMD
RT @BrendonStilesMD: Look how far we have come in lung cancer in a very short time. #lcsm https://t.co/4L7D0EhXmh
Jean Parks @geekbabe
@BrendonStilesMD When I failed platinum doublet I figured I’d be dead within the yr. Research has kept me alive. Thanks for hosting #LCSM
#LCSM content from Twitter.